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ZUSAMMENFASSUNG 
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) ist ein cAMP-abhängiger Cl--
Kanal, der in der apikalen Membran von Epithelzellen exprimiert wird. CFTR spielt eine 
essentielle Rolle in der Elektrolyt- und Wasser-Homöostase. Mutationen im CFTR-Protein 
verursachen die Erkrankung Mukoviszidose (Cystische Fibrose), eine tödlich Erbkrankheit, die 
vor allem bei Kaukasiern auftritt. CFTR fungiert als Cl--Kanal, reguliert aber auch andere 
Ionenkanäle und Transporter. Obwohl CFTR seit mehr als 20 Jahren untersucht wird, bleiben 
viele Fragen bezüglich seiner Funktionen offen. In der vorliegenden Arbeit wurden verschiedene 
Funktionen von CFTR untersucht, die zu einem besseren Verständnis der Rolle von CFTR in 
Epithelzellen führen sollten: Die Regulation von CFTR durch die Adenosinmonophosphat-
abhängige Kinase (AMPK) in vivo und in vitro, die Rolle der CFTR- Mutation S573C für die 
Entwicklung einer Pankreatitis, sowie die neuartige Funktion von CFTR als Sensor der 
extrazellulären Protonenkonzentration und Regulator der Ca2+ abhängigen Cl--Leitfähigkeit 
(CaCC). 
 
Regulation von CFTR durch AMPK in vivo 
Die Rolle der AMPK für den epithelialen Cl- -Transport wurde in vivo mit Hilfe von AMPK-α1 
defizienten Mäusen untersucht. Die Ergebnisse dieser Untersuchungen lassen auf eine wichtige 
Rolle von AMPK für die Regulation der Funktion von CFTR in vivo schließen. Ussingkammer-
Experimente mit Präparaten des Kolons von AMPK-α1 defizienten Mäusen zeigten nach 
Aktivierung von CFTR durch cAMP einen erhöhten CFTR abhängigen Cl- -Strom. Im Gegensatz 
zu gesunden Geschwistertieren, war dieser cAMP-abhängige Cl- -Strom unempfindlich für 
Phenformin, einem Aktivator der AMPK. Zusätzlich bestätigten Messungen der rektalen 
Potenzialdifferenz (RPD) an AMPK-α1 defizienten Mäusen eine basale Erhöhung der RPD und 
eine verstärkte Aktivierung von CFTR durch cAMP gegenüber den Kontrolltieren. Dies sind die 
ersten Daten, die einen hemmenden Effekt der AMPK auf CFTR in vivo zeigen. 
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Mechanismus der Regulation von CFTR durch AMPK 
Es wurde versucht die Phosphorylierungsstellen für AMPK im CFTR- Protein zu identifizieren 
und den Mechanismus der Regulation von CFTR durch AMPK in vitro  zu untersuchen. Hierzu 
wurde die Methode der Expression in Xenopus laevis Oozyten verwendet. In diesem System 
können verschiedene CFTR-Mutationen exprimiert und der CFTR abhängige Cl- -Strom mit Hilfe 
der Spannungsklemme untersucht werden. Im Gegensatz zu den früheren Beobachtungen 
konnte gezeigt werden, dass die Aminosäuren S737 und S768 in der R-Domäne von CFTR von 
AMPK und nicht von der Proteinkinase A (PKA) phosphoryliert werden. Mutationen dieser 
Serine zu Alanin führte zur einer basalen Erhöhung des CFTR- Stroms im nichtstimulierten 
Zustand. Aktivierung von CFTR durch die PKA führte zu einem 4- fach größeren CFTR Strom. 
Dieser Strom konnte weder durch den AMPK-Inhibitor Phenformin noch durch den AMPK-
Aktivator Compount C beeinflusst werden. Zusammenfassend zeigten diese Experimente, dass 
AMPK durch Phosporylierung von S737 und S768 die Ruheaktivität und PKA-abhängige 
Aktivierung von CFTR inhibiert. 
Weiterhin wurde gezeigt, dass die α-Untereinheit von AMPK mit dem C-Terminus von CFTR 
interagiert. Daher kann eine lokale Regulation von CFTR durch die AMPK vermutet werden, 
unabhängig von dem gesamtzellulären AMP/ATP Verhältnis. Aus den Ergebnissen lässt sich 
folgendes Modell ableiten: AMP wird lokal vom Shank2/PDE Komplex gebildet. Dieser Komplex 
ist mit CFTR über eine PDZ- Interaktionsdomäne assoziiert. Die lokale AMP Konzentration führt 
zur Aktivierung der AMPK, die ebenfalls am C-Terminus von CFTR bindet. Die Aktivierung der 
CFTR-nahen AMPK hält den CFTR-Kanal unter Ruhebedingungen geschlossen. 
 
Metformin Behandlung erhöht das Risiko einer Pankreatitis bei CF Patienten 
Metformin ist ein Aktivator der AMPK und wird zur Behandlung von Diabetes mellitus Typ II 
eingesetzt. Die Laktatazidose ist eine häufige sekundäre Komplikation der Metformin-Therapie, 
insbesondere bei Patienten mit Nierenfunktionsstörung, Alkoholmissbrauch oder 
Lebererkrankungen. Auch wurde von Patienten mit Nierenversagen berichtet, bei denen sich 
eine Pankreatitis nach Metformin-Therapie entwickelte. Dieser gab Anlass, die Wirkung von 
Metformin auf die Funktion von CFTR mit der Mutation S573C zu untersuchen, die eine 
Pankreatitis auslösen kann. Während der cAMP aktivierte Cl--Strom des Wildtyp-CFTR von 
Metformin nicht gehemmt wird, ist der cAMP aktivierte Cl--Strom der CFTR Mutante S573C 
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reduziert und durch Metformin hemmbar. Das Phosporylierungsmuster von wtCFTR und S573C-
CFTR war dabei nicht verändert. Intrazelluläre Ansäuerung, z.B. durch eine Laktatazidose, 
führte ebenfalls zu geringer Hemmung von wtCFTR, aber zu fast vollständiger Inhibition von 
S573C-CFTR. Zusammenfassend zeigen diese Daten, dass bei Patienten mit der CFTR 
Mutation S573C die verringerte Aktivierung des CFTR Cl--Stroms durch cAMP funktionell 
ausreichend ist. Während einer Metformin-Therapie besteht jedoch die Gefahr einer kritischen 
Hemmung von S573-CFTR, u. a. im Pankreas, was zu einer Pankreatitis führen kann. 
 
CFTR ermöglicht die Messung einer extrazellulären Azidose und reguliert Ca2+ aktivierte 
Cl- Kanäle 
Im letzten Abschnitt der vorliegenden Arbeit wurden Hinweise gefunden für eine neue Rolle von 
CFTR bei der Messung der extrazellulären Protonenkonzentration. In Xenopus Oozyten konnte 
gezeigt werden, dass die Expression von CFTR notwendig ist, um über eine extrazelluläre 
Ansäuerung den endogenen Ca2+ aktivierten Cl- Kanal (CaCC) zu aktivieren. Dieser Strom ist 
deutlich auswärts gleichrichtend und wird durch DIDS und NPPB inhibiert. In der Abwesenheit 
von intaktem CFTR wird dieser Strom nicht aktiviert. Die Expression von CFTR könnte zu einer 
Translokalisation eines H+- Rezeptors in die Oozytenmembran führen. Bindung von 
extrazellulären Protonen aktiviert die Phospholipase C und führt zum Anstieg der intrazellulären 
H+-Konzentration, was CaCC aktiviert. Die physiologische Bedeutung der CFTR induzierten 
Protonenempfindlichkeit und Aktivierung von CaCC ist unklar. Die CFTR abhängige Expression 
eines H+- Rezeptors könnte für den Knochenmetabolismus und die Mineralisierung eine wichtige 
physiologische Rolle spielen. Osteoporose ist eine bekannte Komplikation der Mukoviszidose. 
Es ist bekannt, dass die Funktion von Osteoblasten und Osteoklasten von der extrazellulären 
Protonenkonzentration bestimmt wird und Kochenzellen CFTR exprimieren. Es ist daher 
möglich, dass bei Mukoviszidose eine Dysfunktion der Protonenmessung vorliegt, was zur 
Osteoporose führen könnte. 
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CHAPTER 1.  
 
Introduction 
Epithelial cells form barriers that protect living organisms from harmful influences and allow 
transport of substrates and electrolytes between different compartments. In order to fulfill these 
tasks, epithelial monolayers are formed that are tightly regulated to allow selective transport 
between the apical and the basolateral compartment. Tight junctions between individual cells 
guarantee limited and selective paracellular transport of ions and water1, while polarized 
distribution of ion channels, substrate transporters and water channels in apical and basolateral 
membranes allow selective and vectorial (unidirectional) transcellular transport. Depending on 
the tissue specific arrangement of these transport proteins in the luminal and basolateral 
membrane, the epithelium will have either secretory or absorptive properties. Secretion and 
absorption of electrolytes, i.e. ions such Na+, K+, Cl-, HCO3-, and water, are main functions of 
epithelial cells present in kidney, airways, intestine, sweat duct and a number of exocrine 
glands2. Apart from electroneutral transport which will not be further discussed in the present 
introduction, electrogenic secretion or absorption of ions across epithelial cells is a major 
determinant of the ion flux across the epithelium. Depending on existing ion gradients across 
apical and basolateral membranes, the membrane potentials, and the arrangement of ion 
channels, transporters and pumps, secretion or absorption of ions will occur. Water will follow 
passively through the paracellular shunt or transcellularly through water channels. 
A number of tightly controlled ion channels and transporters in both apical and basolateral 
membranes are required for proper electrogenic transport. In principle epithelial cells can be 
subdivided into absorptive and secretory cells (Figure1)3. In absorptive cells, present in airways 
and the intestinal epithelium, sodium ions (Na+) are absorbed via the Epithelial Na+ Channel 
(ENaC) while chloride ions (Cl-) are transported paracellulary (Figure 1A). Na+ is pumped out of 
the cell by basolaterallly located Na+/potassium (K+) ATPases, while K+ recycles through 
basolateral K+ channels. Luminal absorption of Na+ and basolateral recycling of K+ will generate 
a lumen negative transepithelial voltage, which drives paracellular absorption of Cl-. ln secretory 
cells, such as submucosal gland cells and epithelial cells in the base of colonic crypts, Cl-, K+, 
and Na+ are taken up into the cell by basolaterally located Na+/K+/2Cl- cotransporters (NKCC1). 
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Na+ is pumped out again by basolateral Na+/K+-ATPases, and K+ exits via basolateral K+ 
channels. Apical (luminal) Cl- secretion is mediated by cAMP-regulated CFTR (Cystic Fibrosis 
Transmembrane Conductance Regulator) Cl- channels, and probably by Ca2+-regulated 
TMEM16A Cl- channels, while in some tissues such as colon and distal airways, K+ is secreted  
by luminal K+ channels. Na+ will move paracellularly between the cells following the lumen 
negative transepithelial voltage produced by luminal Cl- secretion and basolateral K+ transport. 
(Figure1B). The present thesis will focus on the CFTR Cl- channel, its regulation by protein 
kinase and role in cystic fibrosis. 
A) Absorptive cell    B) Secreting cell 
 
Cystic fibrosis (CF) 
Cystic Fibrosis (CF) is the most common fatal genetic disorder among the Caucasian population. 
It is caused by defects in the cystic fibrosis transmembrane conductance regulator (CFTR) that 
plays a crucial role in epithelial Cl- transport. A major secondary complication causing the high 
lethality in CF is due to chronic lung infections4. Malfunction or absence of CFTR in the airway 
Figure 1. Simplified schemes of ion transport in absorptive (A) and secretory epithelial cells (B). A) In 
absorptive cells, Na+ is absorbed via ENaC and exits the cell basolaterally via Na+/K+ ATPases, while K+ 
is transported out through basolateral K+ channels. Cl- moves through the paracellular compartment. 
Water will move passively following ionic gradient through aquaporin water channels (transcellular) or 
through the gap (tight) junctional pathway (paracellular). B) In secretory cells, Cl-, K+ and Na+ enter the 
cell via Na+/K+/2Cl- cotransporters (NKCC1) where Cl- is secreted to the luminal side by CFTR while K+ 
may be secreted by luminal K+ channels. Na+ is pumped out by basolateral Na+/K+ ATPases, while K+ 
leaves the cells via basolateral K+ channels. Na+ is secreted paracellularly and water moves 
transcellularly and through the paracellular shunt pathway. 
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Figure 2. Schematic model represents HCO3- 
transport in pancreas. HCO3- is taken up 
basolaterally via the Na+/HCO3- cotransporter 
(NBC). Moreover HCO3- is produced intracellularly 
with the help of the carboanhydrase (not shown). 
Na+ is pumped out by the basolateral Na+/K+-
ATPase, whereas K+ exits the cell through 
basolateral K+ channels. HCO3- is mainly secreted 
through the apical Cl-/HCO3- exchanger and partly 
directly through CFTR. Cl- taken up by apical Cl-
/HCO3- exchangers recycle to the luminal 
compartment through CFTR. (Model adapted from 
Shumaker et al179)  
surface epithelium reduces Cl- and water secretion into the lumen, probably causing airway 
dehydration, mucus hyperviscosity, and disruption of the mucociliary clearance. These 
complications lead to a vicious cycle of inflammation and bacterial colonization and infection. 
Staphylococcus aureus and Haemophilus influenza are common bacteria affecting CF patients, 
while infections by Pseudonomas aeruginosa indicate a turning point into a severe chronic 
inflammatory lung disease4.  
Other epithelial tissues expressing CFTR, including salivary glands, liver bile ducts, pancreatic 
ducts, small intestine, colon, vas deferens, the cervicouterine tract, and sweat glands5,6, are also 
affected in CF. Similarly to the airway epithelium, some of these tissues also show signs of 
dehydration and are covered with a highly viscous mucus. The thick and sticky mucus blocks 
duct perfusion and destroys the tissues by the inflammatory processes. Thus pancreatitis affects 
around 85% of CF patients5. Because CFTR is expressed abundantly in intestinal epithelia, 
around 20% of infants suffering from CF, develop a meconium ileus7. In the ducts of the sweat 
gland, CFTR is essential for reabsorption of salt. Malfunction of CFTR elevates the sweat salt 
content, which is still a major diagnostic tool 
in CF5.  
CFTR does not only conduct Cl- but is also 
permeable for HCO3-. This may play an 
important role in the airways as well as in the 
small intestine, where defective HCO3- 
transport may contribute to formation of the 
meconium ileus in cystic fibrosis. Also in the 
pancreas the importance of the transport of 
bicarbonate by CFTR is highly relevant. 
Secretion of HCO3- in the pancreatic duct 
alkalinizes the pancreatic juice and 
neutralizes the acid chyme that is entering 
duodenum. Although HCO3- is mainly 
secreted by the Cl-/HCO3- exchanger 
(SLC26) located in the apical membrane of 
pancreatic epithelial cells, CFTR is 
necessary to recycle Cl- over the apical 
membrane, thereby driving bicarbonate 
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secretion. As the bicarbonate concentration rises in the more distal part of the pancreatic duct, 
direct secretion of HCO3- through CFTR Cl- channels will become more important8-10 (Figure 2). 
In CF, the pancreatic tissue shows cystic degeneration and pancreatic fibrosis due to duct 
obstruction and pancreatitis. Degeneration of the pancreas, which indicates a severe state of the 
CF disease, causes a defect in secretion of pancreatic enzymes and consequently malnutrition 
of the patients11.     
CF can be categorized into six classes, according to CFTR production and function4. Class I: no 
CFTR synthesis, class II: inadequate processing of CFTR, class III: improper CFTR regulation, 
class IV: reduced CFTR conductance, class V: partially defective CFTR production, and class 
VI: accelerating CFTR turnover. More than 1,700 CFTR mutations are described meanwhile. 
Deletion of phenylalanine at position 508 (F508del) is a class II mutation that is most common to 
be found in CF patients. F508del causes misfolding of the protein and thus targeting for 
degradation within the endoplasmic reticulum (ER)12. 
 
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR): Properties and 
regulation 
CFTR is a cAMP dependent Cl- channel that is expressed in the apical membrane of epithelial 
cells13. The properties that distinguish CFTR from other Cl- channels can be described as follow: 
1) small single-channel conductance (6-10 pS), 2) linear current-voltage (I-V) relationship, 3) 
anion permeability sequence of Br-≥Cl->I- 4) time and voltage independence of the channel 
gating, and 5) cAMP dependent regulation. CFTR consists of 5 domains including two 
membrane spanning domains (MSD), two nucleotide binding domains (NBD), and one 
regulatory domain (R domain) (Figure 3). Each MSD is composed of 6 transmembrane domains 
that connect the N-terminus with NBDs, R-domain and C terminus. The two MSDs-NBDs are 
joined by a unique R domain. CFTR regulation depends mainly on ATP-binding and hydrolysis 
at both NBDs and phosphorylation of the R domain.  
CFTR nucleotide binding domains (NBD) 
CFTR belongs to the adenosine-triphosphate (ATP) binding cassette (ABC) transporter family13. 
Similar to other members of the ABC transporter family, CFTR contains two NBDs which bind 
and hydrolyze ATP. For other members of ABC transporter, ATP is required for an uphill 
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transport of substrates. In contrast, Cl- moves across CFTR following the electrochemical 
gradient. Thus ATP hydrolysis is not used to drive active uphill transport of Cl-. However, ATP 
hydrolysis is required for channel gating14-16. Together with R domain phosphorylation by protein 
kinase A (PKA), binding and hydrolysis of ATP leads to conformational changes within CFTR 
and thus a change from the closed to the open state. However, the precise conformational 
changes influenced by ATP-binding and hydrolysis are still controversial17-20  So far the model 
proposed by Vergani et al. is most 
widely accepted21. According to this 
binding of ATP molecules to each NBD 
at the core subdomain (head) 
dimerizes both NBDs in a ‘head to toe’ 
configuration (Figure 3). Upon this 
dimerization, CFTR will undergo a 
conformational change which will lead 
to opening of the channel. On the other 
hand, hydrolysis of ATP at NBD2 
dissociates the dimerization22-24, 
therefore causing closure of the 
channel.  
CFTR-R domain phosphorylation   
Although ATP binding and hydrolysis at 
both NBDs is necessary for channel 
gating, the most important regulatory 
step for CFTR gating comes through 
phosphorylation of the R-domain. 
Phosphorylation of CFTR is tightly controlled by the balance between kinases and 
phosphatases. Several kinases phosphorylate CFTR, including Protein Kinase A (PKA), Protein 
Kinase C (PKC), cGMP-dependent protein kinase (PKG), and p60C-SRC. Although CFTR 
phosphorylation by PKG and p60C-SRC have not been widely studied, both have been shown to 
activate CFTR25-27. PKC is known to phosphorylate CFTR at serine residues S686 and S700 in 
vivo28. A study by Jia et al. suggests that pre-exposure of CFTR to PKC promotes PKA 
phosphorylation of CFTR29. It has been claimed that pre-phosphorylation by PKC is required for 
Figure 3. Model of the CFTR. CFTR consists of five 
major components including two membrane spanning 
domains (MSD), two nucleotide binding domains (NBD), 
and a regulatory (R) domain. CFTR is activated by two 
important regulatory steps, including binding of two ATP 
molecules at both NBDs and phosphorylation of the R 
domain by PKA. 
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gating of CFTR by PKA. Nonetheless the mechanisms of PKC-dependent regulation are still 
unclear and await further studies.  
PKA is a cAMP dependent protein kinase. It is the most important kinase phosphorylating CFTR. 
In vivo and mass spectrometry experiments indicate that 8 serines, located in the R domain, 
including S660, S700, S712, S737, S768, S795, and S813, are phosphorylated by PKA28,30,31. 
PKA phosphorylation is crucial for CFTR activation. Studies by Winter and colleagues suggest 
that PKA phosphorylation may in part increase the affinity of ATP binding to both NBDs 
therefore increase the rate of channel opening32,33. 
Another kinase, Adenosine Monophosphate dependent Kinase (AMPK) has also been reported 
recently to interact and phosphorylate CFTR34-38. AMPK is a serine/threonine kinase that forms a 
heterotrimeric complex comprising a catalytic α subunit and regulatory β and γ subunits. AMPK 
is considered as a “low-fuel” sensor that responds to an increase in intracellular AMP/ATP ratio 
such as lowering of intracellular glucose, or stress conditions like hypoxia39. Once AMPK is 
activated, it phosphorylates many downstream targets, triggering catabolic pathways to 
regenerate ATP and switching off biosynthetic pathways and other processes that consume 
ATP. Phosphorylation of CFTR by AMPK inhibits CFTR Cl- current34,35,37,40. However, the 
phosphorylation sites and mechanisms by which AMPK regulate CFTR are still obscure.         
AMPK can be activated by several drugs including biguanidine compounds like phenformin and 
metformin. Phenformin and metformin activate AMPK, in part, by inhibiting complex I of 
respiratory chain, without interfering AMP/ATP ratio41. Phenformin and metformin are drugs used 
to combat type II diabetes by promoting insulin-stimulated glucose uptake into muscles and 
lowering hepatic glucose output41,42. Due to the high incidence of lactic acidosis, phenfomin has 
been withdrawn from clinical use and has been replaced by metformin. Pancreatitis is not a 
common complication of metformin treatment, however two cases of metformin-induced acute 
pancreatitis are described43,44. These patients are reported to have a background of renal failure. 
Treatment with metformin leads to accumulation of metformin within the body, thereby 
developing metabolic acidosis and acute pancreatitis. 
Although CFTR has been extensively studied for more than 20 years, the role of CFTR R-
domain phosphorylation and its role for channel gating are not completely elucidated45-47. Partial 
or complete removal of the R domain (708-853 or 768-830) constitutively activates CFTR in the 
presence of ATP, independently of PKA phosphorylation33,48,49. These data suggest that the R 
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domain inhibits CFTR in a similar fashion as described for the inhibitory “ball and chain” model in 
Shaker K+ channels50. The inhibitory effects of the R domain can be released by removal of R 
domain or by PKA phosphorylation31,48,51. However, studies on single or multiple mutations of 
serines to alanine indicate that not all PKA-phosphorylated serine residues are responsible for 
CFTR activation. Only serines located at positions 660, 795, and 813 are responsible for 
activation of the channel31,33,52-54. Interestingly, mutations of serines 737 and 768 to alanines 
increase CFTR Cl- currents46,53,55-57. These data indicate that S737 and S768 inhibit CFTR, they 
are, therefore, referred to as “inhibitory serines”.  
Taken together the non-phosphorylated R domain inhibits CFTR. This inhibitory action of the R-
domain on CFTR is released by PKA-dependent phosphorylation of several serine residues. 
However, the paradoxical effects of PKA-dependent and AMPK-dependent phosphorylation of 
the different serine residues within the R-domain are far from being understood. The purpose of 
the present study was therefore to gain a mechanistic insight into the control of CFTR by AMPK 
and to demonstrate regulation of Cl- secretion by AMPK in vivo. 
Compartmentalization and local regulation of CFTR 
CFTR interacts with many proteins forming a macromolecular complex that locally regulates its 
activity58. The PDZ-binding domain located in CFTR’s C-terminus plays a crucial role in protein-
protein interaction of CFTR with scaffold proteins, receptors, the cytoskeleton and a number of 
proteins that belong to the cellular signaling machinery. For instance, the PDZ-binding motif at 
the C-terminus of CFTR interacts with PDZ-domains of NHERF1 (Na+/H+ Exchanger Regulatory 
Factor 1). NHERF1 binds to β2 Adrenergic Receptors (β2-AR) located at the plasma membrane 
(Figure 4). When β2-AR are activated by binding of adrenaline, it triggers stimulatory GTP-
binding (Gs) proteins and activation of the adenylyl cyclase, thereby increasing intracellular 
cAMP, which finally activates the CFTR Cl- channel (Figure 4)59. In addition, NHERF1 was also 
described to be important for activation of CFTR through Adenosie 2b Receptor (A2b-R) (Figure 
4)59. NHERF1 contains an ERM (Ezrin, Radixin, Moesin) module which interacts with an 
ezrin/PKA complex. As a consequence, binding of CFTR to NHERF1 brings along PKA which 
will be located into close proximity of the R-domain of the CFTR channel (Figure 4)58-61. The 
nearby located adenylyl cyclase converts ATP into cAMP, while the phosphodiesterase (PDE) 
degrades cAMP and thus removes the signaling molecule. PDE, in particular PDE4D is also 
anchored to the macromolecular complex by a protein named Shank2, which binds to CFTR’s 
PDZ motif62. Competitive binding of NHERF1/PKA and Shank2/PDE4D protein complexes to the 
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Figure 4. Compartmentalized control of CFTR. CFTR interacts with several binding partners mainly 
through CFTR’s PDZ motif. NHERF1/β2-AR/A2b-R and shank2/PDE4 protein complexes bind to the 
PDZ motif in a competitive manner, thus allowing for spatiotemporal control of cAMP levels in close 
proximity to CFTR. NHERF1 interacts with the ezrin/PKA complex, therefore binding of CFTR to 
NHERF1 places PKA into close proximity of the R-domain of the CFTR channel. Phosphatase 2A 
(PP2A) binds to the C-terminal end of CFTR, allowing for dephosphorylation of the R domain, and 
closure of  the channel. 
PDZ motif of CFTR allows for spatiotemporal regulation of cAMP levels and thus local control of 
CFTR activity, independent of global changes in cAMP61,62.  
Thus CFTR phosphorylation and activation of Cl- secretion is regulated by the 
NHERF1/Ezrin/PKA complex and generation of local cAMP levels, while dephosphorylation of 
CFTR and inactivation of Cl- secretion is due to the activity of local phosphatases. Binding of 
Protein phosphatase 2A (PP2A) to CFTR’s C terminus will dephosphorylate CFTR and 
consequently close the channel61. Apart from these well established and important mechanisms, 
other proteins have also been reported to bind and regulate CFTR. For instance, binding of 
SYN1a, SNAP23, and Munc18a reduce channel activity, whereas RACK1 and PKC activate 
CFTR59. Taken together, the available data indicate that macromolecular protein-complexes 
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around CFTR allow for local control of channel activity, independent of global cellular changes of 
signaling molecules. Such a compartmentalized regulation of channel activity occurs 
independent in both apical and basolateral membranes of polarized epithelial cells, and has also 
been reported for Ca2+ dependent regulation of ion channels.  
CFTR as a regulator of other channels 
Although numerous studies describe the role of CFTR as an ATP/PKA regulated Cl- channel, 
CFTR also controls the activity of other ion channels and transporters including ENaC63,64, K+ 
channels (such as ROMK1 and ROMK2)65,66, anion exchangers67-69, and water channels 
(aquaporin)70. Importantly CFTR is also known to regulate other Cl- channel including the so 
called Outwardly Rectifying Cl- Channel (ORCC)71,72, and Calcium (Ca2+)-activated Cl- channel 
(CaCC)73,74. Because CaCC has been proposed as one of the alternative therapeutic targets for 
the treatment of cystic fibrosis4, studies on regulation of CaCC and the relationship between 
CFTR and Ca2+ dependent Cl- secretion are of particular interest.  
CaCC regulation by CFTR 
Ca2+-activated Cl- channels (CaCC) are Cl- channels that are activated by an increase in 
intracellular Ca2+. CaCC are important for many physiological processes. For instance 
membrane excitability, olfactory transduction, regulation of the vascular tone, photoreception, 
and epithelial secretion are all controlled by CaCC75,76. The molecular identity of CaCC has long 
been a mystery until recently when three independent laboratories using three independent 
experimental approaches, identified the protein TMEM16A (also known as ANO1 or DOG1) as 
the major component of CaCC77-79. TMEM16A belongs to a family of 8 transmembrane domain 
proteins, together with 9 others members termed TMEM16B-H, TMEM16J, and TMEM16K (also 
called ANO2-10). Unique properties of CaCC comprise strong outward rectification at 
submaximal Ca2+ concentration (Figure 5), time and voltage dependence of the Cl- current, and 
an anion permeability sequence of I->Cl-. In addition, studies on TMEM16A expression in 
HEK293 cells reveal a very small single channel conductance of CaCC77. Along with the 
discovery of TMEM16A as a major component of CaCC, TMEM16A-/- mice have been 
generated80. These mice demonstrate a very severe phenotype and usually die within 3-5 days. 
Their high lethality is predominantly due to defective development of cartilage rings of the 
trachea. Subsequent electrophysiological studies on TMEM16A knockout animals showed 
defective Ca2+ activated Cl- currents in trachea, colon, hepatocytes, and pancreas of TMEM16A-
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/- mice, supporting the concept of TMEM16A as a major component of CaCC81. TMEM16A was 
also found to be upregulated in Gastrointestinal Stromal Tumors (GIST). Because of its extreme 
abundance in GIST, TMEM16A is used as a marker for clinical diagnosis of GIST82. An 
upregulation of TMEM16A in GIST implies a role of CaCC in cancer development. However the 
function of TMEM16A in cancer is not known and needs to be further elucidated  
CFTR was reported to inhibit CaCC. Overexpression of 
CFTR in bovine pulmonary artery endothelial cells or 
Xenopus oocytes inhibited endogenous CaCC, while 
activation of CFTR completely abolishes current produced 
by CaCC73,74. However the mechanism underlying the 
inhibition of CaCC by CFTR is still poorly understood. On 
the other hand, CaCC activity was described to be 
enhanced in cystic fibrosis, where expression of functional 
CFTR is missing83,84. This finding correlates with another 
observation indicating that intracellular Ca2+ mobilization 
and Ca2+ signaling are increased in human CF airway 
epithelial cells85-87. Hence, augmented Ca2+ activated Cl- 
currents in CF are most likely due to an increase in 
intracellular Ca2+ signaling. 
 
Intention and outline of the present thesis 
The present data indicate that CFTR is a multifunctional protein that shows a complex regulation 
and that interacts with numerous additional proteins. Although CFTR has been studied for more 
than 20 years, many open questions regarding its regulation by AMPK, the functional 
consequences of particular CFTR-mutations and its interaction with other proteins and 
interference with other cellular processes are still remaining. The present thesis therefore aimed 
in elucidating several of these mechanisms. 
AMPK phosphorylation of CFTR has been shown to inhibit CFTR activity in human airway 
epithelial cells34,35,37,40. Although highly interesting, in vivo data on the regulation of CFTR by 
AMPK have never been presented. In chapter 2 of this thesis data are shown on the regulation 
of Cl- secretion by AMPK in vivo. This study makes use of animals in which the relevant AMPK 
Figure 5. IV curve of CFTR and 
CaCC. I/V curves representing the 
current voltage relationships for 
CFTR and CaCC when expressed 
in HEK293 cells. CFTR displays a 
linear IV curve (blue) whereas 
CaCC shows strong outward 
rectification (red). 
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has been knockout out. The data indicate that AMPK does regulate CFTR-dependent transport 
in vivo.  
Chapter 3 continues to focus on AMPK-dependent regulation of CFTR. The phosphorylation 
sites for AMPK within CFTR have never been identified. Moreover, the mechanisms by which 
AMPK regulates CFTR activity were so far unknown. The chapter therefore describes how 
AMPK acts on CFTR, and elucidates the relationship between regulation by protein kinase A 
and AMPK. For the first time the phosphorylation sites for AMPK are described.  
AMPK can be activated by several drugs including biguanidine compounds like phenformin and 
metformin. On the other hand biguanidines have been shown to induce pancreatitis in some 
patients. Pancreatitis is also common in cystic fibrosis and has been correlated with several 
CFTR mutations including S573C. Interestingly, S573C is a non-CF causing mutation, 
associated with pancreatitis88,89. The study described in chapter 4 of the present thesis examines 
the correlation of metformin-induced pancreatitis to the mutation S573C. Using the expression 
system in Xenopus laevis oocytes, the function of S573C-CFTR and its alteration by metformin 
is studied. It was found that the antidiabetic drug metformin alters regulation of CFTR by AMPK. 
Treatment of diabetes in patient carrying the S573C-CFTR mutation by metformin may therefore 
cause a rsik for pancreatitis.  
In the last chapter 5 of this thesis, the focus is on CFTR-dependent sensing of extracellular 
acidic pH, which elicits a transient increase in intracellular Ca2+.  Since this study was performed 
in oocytes of Xenopus laevis, which express endogenous Ca2+ dependent Cl- channels (CaCC), 
CaCC is activated during CFTR-dependent sensing of low extracellular pH. Similar to the 
previously described translocation of ß-adrenergic receptors to the apical membrane of epithelial 
cells, CFTR may also allow for translocation of proton receptors to the plasma membrane. It is 
speculated that H+ sensing in bone cells is CFTR dependent and is impaired in cystic fibrosis, 
thus leading to osteoporosis. 
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CHAPTER 2.  
 
Regulation of Cl- Secretion by AMPK In Vivo  
ABSTRACT 
Previous in vitro studies suggested that Cl- currents produced by the cystic fibrosis 
transmembrane conductance regulator (CFTR; ABCC7) are inhibited by the α1-isoform of the 
adenosine monophosphate (AMP) stimulated kinase (AMPK). AMPK is a serine/threonine 
kinase that is activated during metabolic stress. It has been proposed as a potential mediator for 
transport-metabolism coupling in epithelial tissues. All previous studies have been performed in 
vitro and thus little is known about regulation of Cl- secretion by AMPK in vivo. Using AMPKα1-/- 
mice and wild type littermates, we demonstrate that phenformin, an activator of AMPK, strongly 
inhibits cAMP activated Cl- secretion in mouse airways and colon, when examined in ex vivo in 
Ussing chamber recordings. However, phenformin was equally effective in AMPKα1-/- and wt 
animals, suggesting additional AMPK-independent action of phenformin. Phenformin inhibited 
CFTR Cl- conductance in basolaterally permeabilized colonic epithelium from AMPKα1+/+ but 
not AMPKα1-/- mice. The inhibitor of AMPK compound C enhanced CFTR mediated Cl- 
secretion in epithelial tissues of AMPKα1+/+ mice, but not in AMPKα1-/- mice. There was no 
effect on Ca2+ mediated Cl- secretion, activated by ATP or carbachol. Moreover CFTR-
dependent Cl- secretion was enhanced in the colon of AMPKα1-/- mice, as indicated in Ussing 
chamber ex vivo  and rectal PD measurements in vivo. Taken together, these data suggest that 
epithelial Cl- secretion mediated by CFTR is controlled by AMPK in vivo.  
 
Key words: Cystic fibrosis transmembrane conductance regulator, CFTR, AMPK 
 
Published in: Kongsuphol P, Hieke B, Ousingsawat J, Almaca J, Viollet B, Schreiber R, Kunzelmann K. Regulation of 
Cl- secretion by AMPK in vivo. Pflügers Archiv : European Journal of Physiology 457, 1071-8(2009). 
Own experimental contribution: All open and real short circuit Ussing chamber experiments in mouse trachea and 
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INTRODUCTION 
The cystic fibrosis transmembrane regulator (CFTR) is a Cl- channel at the apical surface of 
many epithelia that is defective in the severe inherited disease cystic fibrosis90. The activity of 
CFTR is regulated by binding of ATP and heterodimerization of both nucleotide binding domains 
along with phosphorylation by protein kinase A (PKA)91-93. Recently a new kinase, the adenosine 
monophosphate dependent kinase (AMPK) has emerged that phosphorylates CFTR at an 
unknown location and inhibits its single channel open probability35,38. AMPK is a ubiquitous 
serine/threonine kinase with orthologous in all eukaryotes. The enzyme exists as a heterotrimer 
with a catalytic α subunit and regulatory β and  γ subunits. In response to metabolic stress and 
rise in the cellular AMP levels, AMPK phosphorylates numerous proteins and activates catabolic 
pathways that generate ATP, while inhibiting cell growth, biosynthesis and other processes that 
consume ATP39. Thus AMPK is regarded as a 'low-fuel' sensor39,94. It acts on a wide range of 
substrates and cellular pathways, including regulation of metabolic pathways controlling 
glycolysis, fatty acid synthesis and oxidation, as well as cellular glucose uptake, and cholesterol 
synthesis. Moreover it controls signaling pathways involved in apoptosis, cell cycle, 
transcriptional regulation, and inflammation95. Recent reports also suggest that AMPK affects the 
activity of proteins involved in electrolyte transport, such as CFTR and the epithelial Na+ channel 
ENaC38,96,97. 
A mouse knockout model for AMPKα1 has been generated some time ago98. The animals 
demonstrate normal survival and did not present any obvious phenotype. It was shown that in 
skeletal muscle AMPKα2 is the predominant catalytic subunit of AMPK and is responsible for 
glucose uptake although during contraction, the two alpha-isoforms seem to substitute for each 
other in terms of activity98. However, the results of another study did not support an essential 
role of either AMPKα1 or AMPKα2 in regulating exercise-induced gene activation in skeletal 
muscle99. Nevertheless, in a subsequent report the authors demonstrated that AMPKα1 but not 
AMPKα2 is necessary for regulation of twitch-contraction stimulated glucose uptake100. In 
general defects in glucose homoeostasis were not observed in AMPKα1−/− mice, while 
AMPKα2−/− mice show high plasma glucose levels and low plasma insulin concentrations in the 
fed period and during the glucose tolerance test101. Apart from these studies not much is known 
about the contribution of AMPK to membrane transport in vivo. At a recent conference data were 
presented that indicate a mild renal phenotype in AMPKα1−/− but not in AMPKα2−/− mice and 
suggested regulation of expression and function of the renal Na+/K+/2Cl--cotransporter NKCC2 in 
the thick ascending limb of the loop of Henle by AMPKα1102.  
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The catalytic isoform AMPKα1 was shown to co-localize with apical CFTR in rat nasal epithelial 
cells and colonic epithelial cells34,38. Inhibitory regulation of CFTR by AMPK has been 
demonstrated in Xenopus oocytes38 and cultured epithelial cells from colonic carcinoma and 
airways34,35,103. Moreover, lack of functional CFTR expression has been suggested to up-
regulate AMPK activity in epithelial cells carrying the CF defect. It was concluded that AMPK 
activation in CF airway epithelial cells is an adaptive response that reduces inflammation. Thus 
therapies have been proposed to activate AMPK in CF airways in order to reduce excessive 
airway inflammation36. However, up to now no data were presented the existence of AMPK-
regulation of CFTR in native epithelial tissues. Using pharmacological tools, epithelial tissues 
from AMPKα1 knockout animals98 and wt littermates, we demonstrate regulation of CFTR by 
AMPK in the native epithelium, which could be particularly relevant under non-stimulated 
conditions. 
 
MATERIALS AND METHODS 
Animals, M1 cells and Ussing chamber experiments: Generation of the AMPKα1 knockout mice 
has been described in a previous report. A LacZ gene was knocked in the AMPKα1 gene using 
gene trp startegy, where LacZ is under the control of the AMPKα1 promoter98. For the Ussing 
chamber measurements, the nasal epithelium, trachea, and colon were removed from AMPKα1 
knockout animals and wild type littermates98, euthanized by ethically approved institutional 
procedures. For genotyping, mouse tail was digested using Viagen DirectPCR-Tail (Viagen 
Biotech, Inc. CA, USA).  The product was subjected to PCR for genotyping using primers  5’-
AGC CGA CTT TGG TAA GGA TG-3’ (s) and 5’-CCC ACT TTC CAT TTT CTC CA-3’ (as) for wt 
and 5’-GGG CTG CAG GAA TTC CAT ATC AAG C-3’ (s) and 5’-CCT TCC TGA AAT GAC TTC 
TGG TGC-3’ (as) for AMPK α1-/-. 
Tissues were put immediately into ice-cold buffer solution of the following composition (mmol/l): 
NaCl 145, KCI 3.8, D-glucose 5, MgCI2 1, HEPES 5, Ca2+ gluconate 1.3. After stripping the 
colonic mucosa and opening of the tracheas by a longitudinal cut, tissues were mounted into a 
micro Ussing chamber with a circular aperture of 0.95 mm2. Mouse M1 kidney collecting duct 
cells (kindly provided by Prof. Dr. C. Korbmacher, Physiologisches Institut, Universität Erlangen, 
Germany) were grown to confluence on permeable supports and mounted into the Ussing 
chamber as described previously63. Luminal and basolateral sides of the epithelium were 
perfused continuously at a rate of 5 ml/min. The bath solution containing (mmol/l) NaCl 145, 
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KH2PO4 0.4, K2HPO4 1.6, D-glucose 5, MgCI2 1, HEPES 5, and Ca-gluconate 1.3, was heated to 
37°C, and pH was adjusted to 7.4. Experiments were carried out under open-circuit conditions. 
Values for transepithelial voltages (Vte) were referred to the serosal side of the epithelium. 
Transepithelial resistance (Rte) was determined by applying short (1 s) current pulses (Δl = 0.5 
µA) and after subtracting the resistance of the empty chamber, using Ohm’s law (Rte = ΔVte / ΔI). 
Transepithelial resistances were 63 ± 3.8 Ωcm2; n = 12 (trachea), 31 ± 2.1; n = 13 (colon) and 
669 ± 45 Ωcm2; n = 38 (M1). For real short circuit measurements basolateral membranes of M1 
cells or mouse colonic epithelium were permeabilized with 75 µg/ml nystatin to eliminate the 
electrical resistance of basolateral membranes. 
Rectal potential different (RPD): For RPD measurements, mice were anaesthetized by 
intraperitoneal injection of 20 µl (75 mg/ml) ketamine and 5 mg/ml xylazine. A catheter 
(polythene tube with OD 1 mm) perfused with standard ringer solution (3 ml/min) was attached 
to an AgCl electrode and inserted 2 cm into the rectum. The catheter was continuously perfused 
with Ringer solution and forskolin (2 µM), ATP (10 µM) and Ba2+ (5 mM) were applied via the 
catheter. 
Immunocytochemistry: The Colon was fixed for 20 min in 0.1 M PBS with 4% paraformaldehyde. 
Sections were embedded in paraffin, cut in 5 µm serial sections (Leica microtome RM 2165, 
Wetzlar, Germany) and mounted on slides. Dehydrated sections were heat-induced for epitope 
retrieval for 20 min. After washing in PBS, sections were blocked and incubated in primary 
antibodies at 4 ºC overnight. Sheep-anti mouse AMPKα1 and AMPKα2 antibodies (Kinasource) 
were used in a 1:50 dilution. The secondary antibody (Alexa Fluoro 350 Donkey anti-Sheep IgG 
was used at a dilution of 1:200 (Molecular Probes). 
Western blotting: Lysates of isolated proximal and distal colonic crypt cells were resolved by 7% 
SDS-PAGE, transferred to Hybond-P (Amersham, Freiburg, Germany) and incubated with the 
antibodies described above. Bands were visualized with goat anti-rabbit IgG conjugated to 
horseradish peroxidase (Acris, Hiddenhausen, Germany) and ECL using a Fluor-STM 
MultiImager (Bio-Rad, Hercules, USA).  
Materials and statistical analysis: All compounds used were of highest available grade of purity 
and were obtained from Sigma or Calbiochem. Student’s t-test and, where appropriate, ANOVA 
was used for statistical analysis. Data are shown as mean values ± SEM. A p value of <0.05 
was regarded as significant. 
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RESULTS 
Expression of AMPK in mouse colon: The mouse colonic epithelium is the predominant site for 
CFTR expression104. We therefore analyzed expression of AMPKα1 and AMPKα2 in proximal and 
distal colon of AMPKα1-/- and AMPKα1+/+ animals (Figure 1). Western blot analysis of lysates 
from isolated colonic crypts and immunohistochemistry demonstrated pronounced expression of 
AMPKα1 in the proximal colon of AMPKα1+/+ animals (Figure 1B,C). Expression of AMPKα1 was 
weaker in colonic crypts of the distal colon and no expression of AMPKα1 was detected in the co 
lon of AMPKα1-/- animals (Figure 1B). AMPKα2 was neither found in the proximal or distal colon 
of wt or AMPKα1 knockout mice (Figure 1B), but was detected in muscle tissue (not shown). 
Moreover, expression of the LacZ transgene under the AMPKα1 promoter was demonstrated in 
the distal colon of AMPKα1+/- animals (Fig1D). 
 
 
Figure 1: AMPKα1 but not 
AMPKα2 is expressed in 
mouse colonic epithelium: 
A) RT-PCR analysis of 
AMPKα1 +/+, AMPKα1 -/- 
and heterozygous animals. 
B) Western blot analysis of 
AMPKα1 and AMPKα2 in 
proximal and distal colon of 
AMPKα1 +/+, and AMPKα1 
-/- animals. C) 
Immunohistochemistry of 
AMPKα1 and AMPKα2 in 
AMPKα1 +/+ mice. Negative 
control indicates staining 
without primary antibody. D) 
Expression of the LacZ 
transgene under the 
AMPKα1 promoter in distal 
colon of AMPKα1+/- animals. 
 
18  Regulation of Cl- Secretion by AMPK In Vivo 
 
Ion transport by CFTR is regulated by AMPK in mouse colon: We examined the effects of the 
AMPK-inhibitor compound C (80 µM, 30 min) and the AMPK-activator phenformin (1 mM, 1h) on 
ion transport in non-stimulated tissues, after mounting the tissues in a perfused Ussing chamber. 
Compound C slightly but significantly enhanced baseline transport, suggestive of basal AMPK 
activity in the non-stimulated tissue, particularly in the colon of AMPKα1+/+ mice (Figure 2A). 
This is further confirmed by the results obtained in non-stimulated epithelial tissues of AMPKα1-/- 
animals (Figure 2B). Here compound C had no effects on ion transport. 
 
Enhanced CFTR Cl- secretion in AMPKα1-/- animals:  We compared regulation of CFTR by 
AMPK in epithelial tissues from nose (Figure 3A,B), trachea (Figure 3C,D) and colon (Figure 
3E,F) of AMPKα1+/+ animals, by stimulating Cl- secretion with IBMX (100 µM) and forskolin (2 
µM) (I/F) in the absence or presence of compound C. In all tissues, I/F induced a negative 
voltage deflection indicating activation of CFTR Cl- conductance (Figure 3). Activation of CFTR 
in nasal, tracheal and colonic epithelium was enhanced after inhibition of AMPK by compound C 
(Figure 3). We compared CFTR dependent Cl- transport activated by IBMX and forskolin in wt-
animals and AMPKα1-/- mice. We found a slight but significant increase in Isc by compound C in 
Figure 2: Enhanced basal ion transport by inhibition of AMPK in AMPKα1 +/+ but not in AMPKα1 
-/- mice: Summary of equivalent short circuits currents (Isc) measured in isolated non-stimulated nasal 
epithelium, trachea and colonic epithelium of AMPKα1 +/+ (A) and AMPKα1 -/- (B) mice.  Inhibition of 
AMPK by compound C (80 µM, 1 h) slightly but significantly enhanced Isc in epithelial tissues of 
AMPKα1 +/+, but not AMPKα1 -/- animals. (number of animals). *significant effects when compared to 
control (paired t-test). 
Regulation of Cl- Secretion by AMPK In Vivo 19 
epithelia from AMPKα1+/+ animals. This was not observed in AMPKα1-/- mice. Moreover, CFTR-
dependent Cl- secretion was enhanced in the colon of AMPKα1-/- mice (Figure 3F). The 
differences between AMPKα1-/- and wild type littermates were most pronounced in the colon, 
probably because of the important role of CFTR for Cl- secretion in the mouse intestine, while 
CFTR was shown to be less essential in mouse airways105,106.  
We further examined whether AMPK affects Ca2+ dependent Cl- secretion in mouse trachea and 
colon, when activated by ATP (100 µM) and carbachol (CCH, 100 µM), respectively. Ion 
transport activated by Ca2+ was indistinguishable between wt and AMPKα1 knockout animals 
(Figure 4). There was also no effect of compound C on Ca2+ activated Cl- conductance in 
trachea or colon (Figure 4B,D). Thus no clear evidence exists for a regulation of Ca2+ dependent 
Cl- secretion by AMPK. We further tried to make use of the activator of AMPK, phenformin (1 
Figure 3: Enhanced CFTR-mediated ion transport by inhibition of AMPK in AMPKα1 +/+ but not in 
AMPKα1 -/- mice: Original recordings of the transepithelial voltage and comparison of the IBMX (100 
µM)/forskolin (2 µM) induced equivalent short circuits currents (Isc) measured in ex vivo tissues of nose 
(A,B), trachea (C,D) and colon (E,F) of AMPKα1 +/+ and AMPKα1 -/- mice. Black bars indicate 
stimulation of Cl- secretion in the presence of compound C (80 µM, 1 h). (number of animals). *significant 
effects when compared to control (paired t-test). 
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mM, 1h incubation). However, phenformin inhibited CFTR-dependent Cl- secretion in all 
epithelial tissues examined from AMPKα1-/- and AMPKα1+/+ animals (Figure 5). Moreover, Ca2+ 
dependent Cl- secretion activated by ATP or carbachol was inhibited by phenformin in wt and 
knockout animals (data not shown). We therefore suggest that phenformin has a rather non-
specific effect on cellular electrolyte transport and may also inhibit other transport proteins such 
as the Na+/K+-ATPase107. Thus phenformin was not useful in our study to examine AMPK-
dependent regulation of CFTR in AMPKα1-/- and AMPKα1+/+ animals. 
 
 
 
This finding was further substantiated by additional experiments performed in the mouse 
collecting duct cell line M1. Activation of ion transport by IBMX and forskolin was not affected by 
compound C but was inhibited by phenformin (data not shown). 
Figure 4: Lack of evidence 
for regulation of Ca2+ 
dependent Cl- secretion by 
AMPK: Original recordings of 
the transepithelial voltage and 
summaries of the short circuit 
currents activated through 
Ca2+ dependent stimulation of 
trachea (A,B) and colonic 
(C,D) epithelium of AMPKα1 
+/+ and AMPKα1 -/- mice. 
Negative transient voltage 
deflections were induced by 
luminal ATP (100 µM; trachea) 
and basolateral carbachol (100 
µM; colon). The summaries of 
the Ca2+ activated equivalent 
Isc indicate no effect of 
compound C and no difference 
between AMPKα1 +/+ and 
AMPKα1 -/- animals. (number 
of animals). 
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To eliminate the contribution of basolaterally located proteins to electrolyte transport, the 
basolateral membranes of mouse colonic ex vivo tissues were permeabilized using nystatin (75 
µg/ml). The epithelium was exposed to a transepithelial Cl- gradient, in which 140 mmol/l Cl- on 
the basolateral side have been replaced by equal amounts of  gluconate. In these experiments, 
phenformin inhibited Isc in colonic epithelium of AMPKα1+/+ but not AMPKα1-/- mice (Figure 7A). 
Moreover, I/F induced Cl- conductance appeared to be larger in the AMPKα1-/- colon, although 
the difference did not reach significance (Figure 7B). Similar experiments were performed on 
mouse collecting duct cells grown on permeable supports. IBMX and forskolin activated a 
pronounced Isc that was inhibited by 5 µM of the specific CFTR-inhibitor CFTRinh172 or by 
phenformin (1-3 mM), indicating inhibition of CFTR in the luminal membrane of M1 cells by 
AMPK (Figure 6).  
We further performed measurements of the rectal potential difference (RPD) in vivo, using a 
perfused rectal catheter and a reference electrode under the skin of anaesthetized mice. The 
RPD of AMPKα1-/- animals was significantly enhanced when compared to the AMPKα1+/+ 
Figure 5: Phenformin inhibits CFTR-mediated ion transport independent of AMPKα1 
expression: Original recordings of the transepithelial voltage and comparison of the IBMX (100 
µM)/forskolin (2 µM) induced equivalent short circuits currents (Isc) measured in ex vivo tissues of 
nose (A,B), trachea (C,D) and colon (E,F) of AMPKα1 +/+ and AMPKα1 -/- mice. Black bars indicate 
stimulation of Cl- secretion in the presence of phenformin (1 mM, 1 h). (number of animals). 
*significant effects when compared to control (paired t-test). 
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Figure 6: Effect of AMPK 
on ion transport in 
mouse collecting duct 
cells. Ion transport 
assessed in M1 cells after 
permeabilization of the 
basolateral membrane 
with 75 µM nystatin. A,B) 
Activation of apical CFTR-
conductance is reduced in 
the presence of the 
specific inhibitor 
CFTRinh172 (5 µM). C,D) 
Activation of apical CFTR-
conductance is reduced in 
the presence of the AMPK 
inhibitor phenformin (1 
mM). (number of 
monolayers). *significant 
effects when compared to 
control (paired t-test). 
rectum (Figure 7C,D). After perfusion of the rectum with 2 µM forskolin, the RPD increased 
significantly in both AMPKα1+/+ mice and AMPKα1-/- mice. The forskolin induced increase in 
RPD was significantly enhanced in the AMPKα1-/- rectum, suggesting enhanced CFTR-Cl- 
conductance in the large intestine of mice lacking AMPKα1 expression (Figure 7E). Finally, 
activation of luminal K+ secretion by perfusion with ATP (10 µM)108, or inhibition of luminal K+ 
channels with barium (5 mM) caused similar changes in both AMPKα1+/+ mice and AMPKα1-/- 
mice, indicating AMPK-inhibition of CFTR Cl- channels but not of Ca2+ dependent K+ transport in 
the large intestine of mouse (Figure 7F). 
 
DISCUSSION 
Evidence for AMPK-dependent regulation of CFTR in vivo: AMPKα1 is co-localized with apical 
CFTR in epithelia of airways and colon 34,35. Inhibition of CFTR-dependent Cl- secretion has 
been demonstrated in various in vitro models including Xenopus oocytes 38 and cultured 
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Figure 7: Enhanced 
CFTR-dependent ion 
transport in AMPKα1 -/- 
animal. A) Original 
recording of the real short 
circuit current assessed in 
basolaterally 
permeabilized (75 µM 
nystatin) colonic 
epithelium of an AMPKα1 
+/+ animal. A,B) 
Activation of CFTR-
dependent Cl- secretion in 
the colon of AMPKα1 +/+  
animals is inhibited in the 
presence of phenformin 
(1 mM, 1h), but not in the 
colon of AMPKα1 -/- 
mice. C) Original 
recording from a 
measurement of the rectal 
potential difference in vivo 
using a perfused catheter. 
Both baseline RPD (D) 
and forskolin (10 µM) 
induced RPD-increase (E) 
are enhanced in AMPKα1 
-/- mice. F) Ca2+ (100 µM 
ATP) and Ba2+ (5 mM) 
induced RPD-changes 
are identical in AMPKα1 
+/+ and AMPKα1 -/- 
animals. (number of 
animals). *significant 
effects when compared to 
control (paired t-test). 
#significant effect when 
compared to AMPKα1 +/+ 
mice (ANOVA).  
 
epithelial cells from large intestine and airways34,35,103. The present experiments, for the first 
time, provide evidence that AMPK-dependent regulation also takes place in vivo.  Most of the 
results presented here were obtained from ex vivo tissues. At the first glance the data suggest a 
rather limited impact of AMPK on CFTR-dependent transport. However several aspects have to 
be taken into account to fully appreciate the present results: i) We have no real control over the 
metabolic status in the tissues examined ex vivo. ii) The drugs used in the present study may 
only partially inhibit or activate AMPK activity, since we had to limit both incubation time and 
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concentrations. iii) Compensatory mechanisms may take place in the AMPKα1-/- animals, which 
could mask the regulatory impact of AMPK on CFTR. iv) Mouse colon shows strong CFTR 
expression while little CFTR is expressed in the airways106.  
Other factors should to be taken into account that might affect epithelial transport properties in 
AMPKα1–/– animals indirectly. These animals show additional pathological features which are 
currently not well understood. We found that they also have a reduced hematocrit and enlarged 
spleens, which points out to abnormal hematopoeisis. As reported recently, the major 
phenotypic changes observed in AMPK1-KO mice is a splenomegaly, possibly due to the 
massive amplification of erythroid nucleated cells. Moreover, immunohistology revealed 
abnormal development of the red pulp with a significant increase in the number of erythroid 
precursors109. 
Phenformin was inhibiting CFTR dependent Cl- secretion also in the AMPKα1-/- animals, 
although there is no evidence for expression of the AMPKα2 isoform in epithelial cells from 
airways and the intestine. Woollhead and collaborators demonstrated that both phenformin and 
AICAR have additional pharmacological effects on the Na+/K+ -ATPase, which are probably 
independent of AMPK107. In their experiments phenformin and AICAR inhibited the Na+/K+ -
ATPase, which reduced reduces Na+ absorption by the epithelial Na+ channel ENaC. There are 
currently no detailed reports on AMPK regulation of the Na+/K+ - ATPase; although reduced ATP 
supply due to cellular energy depletion clearly inhibits the function of the Na+/K+ - pump. The 
Na+/K+ - ATPase is the largest consumer of cytosolic ATP. Renal epithelial cells use up as much 
as 50% of their total mitochondrial oxidative metabolism during ion transport110. Since the Na+/K+ 
-ATPase is equally important for Cl- secretion as for Na+ absorption, blockage of the pump by 
phenformin probably explains inhibition of CFTR-mediated Cl- secretion in the present study. 
Thus, the effects of phenformin in ex vivo tissues of AMPKα1-/- animals are unrelated to 
AMPKα1-function and therefore cannot be taken as a measure for AMPK activity. Nevertheless, 
the present experiments with the AMPK inhibitor compound C clearly supply evidence for 
inhibition of CFTR by AMPK in the native tissue, as CFTR dependent Cl- secretion was inhibited 
by activation of AMPK in native airways and intestinal epithelia ex vivo. Moreover, inhibitory 
regulation of electrolyte secretion by AMPKα1 in vivo is clearly suggested by the rectal PD 
measurements.  
Physiological role of AMPK-regulation of CFTR:  Is CFTR Cl- secretion turned off under cellular 
ATP depletion? This concept has been proposed recently. It would allow adjusting energetically 
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expensive electrogenic Cl- secretion to the actual energy supply38,96. Assuming such a scenario, 
we would expect pronounced activity of AMPK particularly in heavily transporting epithelia, i.e. 
after maximal increase of intracellular cAMP. Under such conditions ATP consumption by the 
Na+/K+-ATPase should be rather high, the ATP: AMP ratio should drop and thus activate AMPK. 
However, Data from our laboratory suggests the opposite, namely reduced inhibitory effects of 
AMPK on CFTR Cl- conductance during maximal activation of CFTR111. At any rate, CFTR Cl- 
secretion was clearly enhanced in the colonic epithelium of AMPKα1 knockout animals and the 
differences to wt animals was particularly evident in measurements of the rectal potential 
difference (Figure 7). It is therefore concluded that AMPK is a physiologically relevant regulator 
of CFTR-dependent Cl- transport.  
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CHAPTER 3.  
 
Mechanistic Insight into Control of CFTR by AMPK  
ABSTRACT 
The cystic fibrosis transmembrane conductance regulator (CFTR) is a cAMP and protein kinase 
A (PKA) regulated Cl- channel in the apical membrane of epithelial cells. The metabolically 
regulated and adenosine monophosphate stimulated kinase (AMPK) is colocalized with CFTR 
and attenuates its function. However, the sites for CFTR-phosphorylation and the precise 
mechanism of inhibition of CFTR by AMPK remain obscure. We demonstrate that CFTR 
normally remains closed at baseline, but nevertheless opens after inhibition of AMPK. AMPK 
phosphorylates CFTR in vitro at two essential serines (S737 and S768) in the R-domain, 
formerly identified as ‘inhibitory’ PKA sites. Replacement of both serines by alanines i) reduced 
phosphorylation of the R-domain, with S768 having dramatically greater impact, ii) produced 
CFTR channels that were partially open in the absence of any stimulation, iii) significantly 
augmented their activation by IBMX/forskolin and iv) eliminated CFTR inhibition post AMPK 
activation. Attenuation of CFTR by AMPK activation was detectable in the absence of cAMP-
dependent stimulation but disappeared in maximally stimulated oocytes. Our data also suggest 
that AMP is produced by local phosphodiesterases in close proximity to CFTR. Thus we propose 
that CFTR channels are kept closed in non-stimulated epithelia with high baseline AMPK activity 
but CFTR may be basally active in tissues with lowered endogenous AMPK activity.  
 
Key words: Cystic fibrosis transmembrane conductance regulator, phosphorylation, AMP, PKA, 
AMP-activated protein kinase, ion transport.  
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INTRODUCTION 
The cystic fibrosis transmembrane regulator (CFTR) gene is mutated in patients with cystic 
fibrosis. CFTR has an adapted ABC transporter structural motif thereby creating an anion 
channel at the apical surface of secretory epithelia90. The consequent CFTR-mediated ion 
transport is tightly controlled by ATP binding and phosphorylation by protein kinase A (PKA). 
However a number of other protein kinases including PKC, Ca2+/calmodulin-dependent kinase, 
and cGMP-dependent kinase also control CFTR’s activity3,17,46. These kinases converge on the 
regulatory domain of CFTR that is unique not only within the large ABC transporter family but 
among all known sequences, and may be considered as a “phosphorylation control module”. 
Regulation of CFTR by an inhibitory kinase, the adenosine monophosphate dependent kinase 
(AMPK), has been described recently but the regulatory sites within CFTR, the mechanism of 
regulation and the physiological relevance have all remained obscure34,35,38,103. Additionally, 
CFTR mutation is linked to inflammation and a lack of functional CFTR expression has itself 
been suggested to up-regulate AMPK activity in epithelial cells carrying the cystic fibrosis (CF) 
defect. Pharmacologic AMPK activation was shown to inhibit secretion of inflammatory 
mediators36. Thus AMPK may play multiple roles in CF pathophysiology making the mechanism 
of interaction an important problem in biology. 
AMPK is a ubiquitous serine/threonine kinase that exists as a heterotrimer with a catalytic α 
subunit and regulatory β and γ subunits, each with multiple isoforms. In response to metabolic 
depletion and a consequent increase in the cellular AMP to ATP ratio, AMPK phosphorylates 
numerous proteins and activates catabolic pathways that generate ATP, while inhibiting cell 
growth, protein biosynthesis and a number of other ATP-consuming processes, thereby 
operating as a cellular 'low-fuel' sensor39,94. AMPK also controls signaling pathways involved in 
apoptosis, cell cycle, and tissue inflammation95. Because AMPK is a cellular metabolic sensor 
that inhibits CFTR and limits cAMP activated Cl- secretion, a coupling of membrane transport by 
CFTR to cellular metabolism has been proposed96. However, AMPK activity can also increase 
without detectable changes in the cytosolic AMP to ATP ratio, suggesting a contribution of 
additional AMP-independent signals for regulation of CFTR by AMPK40. Drugs used to combat 
type 2 diabetes, such as phenformin and metformin, act in this manner to activate AMPK, AMP-
independently. It is also likely that cytosolic AMP is compartmentalized depending on the 
distribution of AMP generating enzymes such as phosphodiesterases that convert cAMP to 
AMP. The concept of spatiotemporal control of cAMP signaling by anchored protein complexes 
is well established61. CFTR is known to form such macromolecular complexes with a number of 
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interacting partners59,60,112. For example, competitive interaction of NHERF1-PKA and Shank2-
PDE4D with CFTR has been demonstrated recently62. In addition, Barnes and coworkers 
demonstrated that phosphodiesterase 4D generates a cAMP diffusion barrier local to the apical 
membrane of the airway epithelium 113. It is therefore likely that activatory pathways through 
cAMP and inhibitory AMP/AMPK-signaling occur in a local CFTR-organized compartment. Here 
we explore the functional links between CFTR, inhibition of phosphodiesterases and AMPK 
focusing on the effects of mutating putative AMPK targets within the R domain on CFTR 
function. 
 
MATERIALS AND METHODS 
cRNAs for CFTR and double electrode voltage clamp: Oocytes were injected with cRNA (10 ng, 
47 nl double-distilled water) encoding wtCFTR, L1430A/L1431A, F508del-CFTR, G551D-CFTR, 
S768A, S737A, S768D, S737D, E1474X, and AMPKα1. All mutants were generated by PCR 
and correct sequences were confirmed by restriction digest and by sequencing. Water injected 
oocytes served as controls. 2 - 4 days after injection, oocytes were impaled with two electrodes 
(Clark Instruments Ltd, Salisbury, UK), which had a resistance of < 1 MΩ when filled with 2.7 
mol/l KCI. Using two bath electrodes and a virtual-ground head stage, the voltage drop across 
the serial resistance was effectively zero. Membrane currents were measured by voltage 
clamping (oocyte clamp amplifier, Warner Instruments LLC, Hamden CT) in intervals from -60 to 
+40 mV, in steps of 10 mV, each 1 s. The bath was continuously perfused at a rate of 5 ml/min. 
All experiments were conducted at room temperature (22 °C). 
Oocyte staining: Oocytes were incubated for 60 min in ND96 solution (in mM: 96 NaCl, 2.0 KCl, 
1.8 CaCl2, 1.0 MgCl2, 5.0 HEPES, pH 7.4), fixed for 60 min with 3% paraformaldehyde (in TBS, 
pH 8.0) and washed in TBS. After embedding in optimum cutting temperature compound 
(Sakura Finetek Europe, Zoeterwoude, NL), oocytes were cut to 20 μm slices with a cryostat 
(Leica CM3050 S, Wetzlar, Germany). Sections were put in either TBS or phosphate buffered 
saline (PBS; (mM) 137 NaCl, 1.8 KH2PO4, 10.3 Na2HPO4, pH 7.4), incubated for 5 min in 0.1% 
(w/v) SDS in PBS and washed 2 times with either TBS or PBS. Sections were incubated for 60 
min in TBS or PBS (5% BSA) and for 60 min at 37°C with the anti-Flag M2 antibody diluted 1:50 
in 2% BSA/TBS or a goat polyclonal casein kinase IIα antibody (Santa Cruz Biotechnology, 
Heidelberg, Germany) diluted 1:25 in 2% BSA/PBS. Afterwards sections were washed twice in 
PBS and incubated for 1 h with secondary antibodies (donkey anti-mouse IgG- Alexa Fluor 488 
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conjugated and donkey anti-goat IgG-Alexa Fluor 546 conjugated; Molecular Probes, Eugene, 
OR) at a dilution of 1:1000 in 2% BSA/PBS. Sections were washed 2 times with PBS for 5 min 
and covered with DakoCytomation fluorescent mounting medium (DakoCytomation, Inc., 
Carpinteria, CA). Images were obtained using a Zeiss Axiovert 200M microscope with a × 63 
objective (Carl Zeiss, Inc., Jena, Germany). 
Immunofluorescence: Nasal ciliated epithelial cells harvested from the inferior turbinate of 
patients undergoing unrelated surgery (approved by local ethical committee) were maintained in 
cell culture medium M199 prior to fixation in 4% paraformaldehyde.  Cells were permeabilized 
using 1% Triton X-100, washed 3 times in PBS, then blocked in 1 mM glycine for 15 min, 
followed by 5% donkey serum for 15 min.  Pelleted cells were resuspended in PBS containing 
primary antibodies (goat anti-CK2α (Santa Cruz) and mouse anti-CFTR NBD1 (Neomarkers) at 
a 1:100 dilution) and incubated at room temperature, with shaking, overnight.  After 3 washes in 
PBS, pelleted cells were resuspended in PBS containing FITC-labeled anti-goat and rhodamine-
labeled anti-mouse IgG secondary antibodies (Jackson, 1:100).  After 2 h incubation with 
shaking the cells were washed five times in PBS and resuspended in 15 μl anti-fade mountant 
(6% n-propyl gallate in 70% glycerol, 100 mM Tris/HCl, pH 7.4) for mounting on glass slides.  
Coverslips were sealed with nail varnish for image capture using a Zeiss 510 laser scanning 
confocal microscope. 
In vitro phosphorylation: Recombinant R domain was phosphorylated with recombinant AMPK 
(Calbiochem 171536) or PKA (NEB P6000S) and peptides were separated subsequently by two-
dimensional electrophoresis as described earlier114. In brief, for AMPK phosphorylation, onto 
approx 20 µl packed volume of substrate beads (approx 2 µg protein), 20 µl of kinase reaction 
buffer was added.  32 mM Hepes pH 7.4, 0.65 mM DTT, 0.012 % Brij-35, 200 µM AMP (if 
included in that particular assay), 100 µM ATP, 10 mM MgAc and approx 500-800 cpm/pmol 
[gamma32P]-ATP.  0.1 units of enzyme activity was added per reaction (as defined by the 
manufacturer's SAMS assay) and incubated at 30 °C for 15 minutes before being washed 3 
times with 1 ml ice-cold 50 mM Tris pH 7.5.  The beads were then resuspended in SDS sample 
buffer and separated on 10 % SDS PAGE, coomassie stained to visualize protein, dried and 
analyzed via autoradiography.  For PKA reactions, manufacturer’s 10x buffer was diluted adding 
0.1 U of PKA with 100 µM ATP (approximately 500-800 c.p.m.).  For mapping purposes the 
gamma ATP concentration was increased 10 fold and the ATP concentration reduced to 50 µM 
to increase the incorporation of radioactive signal in the tryptic peptides. The S768A mutant of 
CFTR abrogated almost entirely phosphorylation by AMPK. 
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Figure 1:  Effect of AMPK on CFTR.  A,B) Whole cell currents activated by IBMX (1 mM) and forskolin (2 
µM) in CFTR expressing oocytes showing the small effects of the AMPK activator AICAR (1 mM) (left) and 
compound C (right). C) Summary of the effects of compound C (80 mM), AICAR (1 mM) and phenformin (1 
mM) on CFTR whole cell conductances activated by IBMX and forskolin. D) Whole cell currents activated by 
IBMX and forskolin in wtCFTR and L1430A/L1431A-CFTR expressing oocytes. E) Summary of whole cell 
conductance generated by wtCFTR and L1430A/L1431A-CFTR and effects of activators and inhibitors of 
AMPK. F) Comparison of the effects of compound C (80 µM) on whole conductances generated by 
wtCFTR, F508del-CFTR, and G551D-CFTR. Membrane currents were measured by voltage clamping in 
intervals from -60 to +40 mV, in steps of 10 mV. ∗ significant difference when compared to control. # 
significant difference when compared to wtCFTR. Data are shown as mean ± SEM, (number of 
experiments). 
Materials and statistical analysis: All compounds used were of highest available grade of purity 
(SIGMA or Calbiochem). R-domain construct was kindly supplied by Dr. J. Hanrahan 
(Department of Physiology, McGill University, Montréal, Canada). The construct encodes for a 
His tagged R-domain of human CFTR containing amino acids 635 to 837. Compounds were 
applied after fully activating CFTR unless otherwise stated. Alternatively oocytes were stimulated 
with I/F in the absence or presence of compounds. Student’s t-test was used for statistical 
analysis. A p value of <0.05 was regarded as significant. 
 
RESULTS 
CFTR is inhibited by baseline activity of AMPK: Figure 1 shows that cyclic AMP/PKA activated 
whole cell Cl- currents in Xenopus oocytes expressing CFTR. The CFTR current was slightly but 
significantly inhibited by activators of AMPK such as membrane permeable 5-aminoimidazole-4-
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carboxamide 1-beta-D-ribofuranoside (AICAR, 80 µM for 1 hour)115 or phenformin (1 mM, 1 h)   
(Figure 1A,C). In contrast to these small inhibitory effects of AICAR and phenformin, CFTR 
whole cell conductance was doubled by the AMPK-inhibitor compound C, suggesting the 
presence of a latent constitutive inhibition of CFTR by a tonic baseline AMPK activity (Figure 
1B,C). This is consistent with the recognized and substantial activity of AMPK in the absence of 
AMP (note the designation of the kinase is AMP-activated and not AMP-dependent). 
Interestingly, the application of compound C alone also activated CFTR without the need for 
PKA stimulation. To exclude a non-specific effect of compound C, we expressed a CFTR mutant 
(L1430A/L1431A), which has been proposed to eliminate binding of AMPKα1 to a C-terminal 
region of CFTR38. This mutant showed a much higher conductance (Figure 1D,E), which was not 
further augmented by compound C or inhibited by the two recognized AMPK activators, AICAR 
or phenformin (Figure 1E). Also two common CFTR-mutants, F508del-CFTR and G551D-CFTR 
could not be further activated by inhibition of AMPK with compound C (Figure 1F). 
This enhanced activity of L1430A/L1431A–CFTR was similar to that seen with wild type CFTR 
first exposed to compound C and then activated by PKA. Thus local AMPK bound to CFTR is 
likely to be essential for inhibition of the maximum CFTR current post PKA stimulation. The 
proximity of the two proteins was further confirmed as shown in Figure 2A. CFTR (red) and 
AMPKα1 (green) are colocalized in an apical compartment of human nasal epithelial cells, thus 
confirming previous results38. Activation of AMPK in Xenopus oocytes by phenformin did not 
change the expression of CFTR in membranes of Xenopus oocytes (Figure 3), confirming 
previous results indicating inhibition of CFTR’s open probability by AMPK 35.   
Inhibitory R-domain sites are targeted by AMPK: It is not known where AMPK phosphorylates 
the CFTR protein38 but the R domain of CFTR contains multiple phosphorylation sites for PKA. 
Interestingly two of these sites, namely S737 and S768, have been identified as ‘inhibitory’ R-
domain sites, i.e. when mutated to alanines they augment CFTR’s open probability relative to 
wild type53,55. We hypothesized that these sites might be phosphorylated by AMPK (rather than 
‘inhibited’ by PKA) given some sequence homology with the expected consensus sequence for 
AMPK in local amino acids and therefore examined in vitro phosphorylation of isolated singly or 
doubly mutant or wild type R-domain protein. Figure 2B demonstrates that AMPK indeed 
phosphorylates the R-domain in vitro and this AMPK phosphorylation is largely reduced in the R-
domain mutants S737A and S768A (compare lanes 2 and 3 in Figure 2B lower panel). The data 
also suggest that serine 768 has a much greater reductive impact because S768A almost 
Mechanistic Insight into Control of CFTR by AMPK 33 
 
Figure 2:  Expression and phosphorylation of CFTR. A) 
Immunostaining of CFTR (red) and AMPKα1 (green) in human nasal 
epithelial cells. B) Phosphorylation of the R domain with PKA and 
AMPK. AMPK phosphorylation was largely reduced or abolished in 
S737A and S768A, respectively (lower panel). When PKA alone was 
used to phosphorylate the R domain, a complex gel shift with some 
diminution of phosphorylation was found after mutation of the two 
serines. This shift was not observed when AMPK alone was the 
phosphorylating kinase but serine mutation abrogated the 
phosphorylation (lower panel). C) Order dependence of AMPK and 
PKA in R domain phosphorylation. PKA and AMPK dependent 
phosphorylation of R domain creates distinct peptides patterns. 
Recombinant R domain phosphorylated with recombinant AMPK in 
the presence of unlabelled ATP (lower left) followed by PKA and 
labelled ATP gives rise to some measurable incorporation. However 
when the PKA was added first, AMPK could only phosphorylate to a 
level approximately 4 fold less than that with PKA or AMPK alone. D) 
Effect of mutating serines S737 and S768 at AMPK phosphorylation 
sites. The S768A mutant abrogates almost all the phosphorylation. 
Electronic autoradiography was done at identical gain settings.  
abolished all the 
phosphorylation whereas 
some was preserved with 
S737A. Crucially, the double 
mutant labeling was similar 
to S768A alone. We 
quantified data from 3 
independent experiments 
and found that the S737A 
mutation leads to a small 23 
± 8 % reduction in counts, 
while S768A leads to a 
major 81 ± 5 % (mean ± 
range) reduction similar to 
the double mutant (87% ± 4 
%) when compared to the wt 
(100%).  Thus the data 
confirm that AMPK targets 
S768 preferentially and also 
phosphorylates S737. The 
specificity of this finding was 
confirmed towards AMPK 
because no such dramatic 
inhibition of labeling of the R 
domain was found when 
PKA was used to 
phosphorylate the R domain 
in vitro (compare upper and 
lower panels in Figure 2B). 
The gel shifts observed with 
PKA (but not AMPK) in the 
presence of these mutants 
are unexplained but are 
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Figure 3: Expression of 
CFTR in the membrane of 
Xenopus oocytes.  
Immunohisto-chemistry of 
CFTR expression (arrows) in 
the absence or presence (2 
hours treatment) of 
phenformin (2 mM). Negative 
control indicates staining 
without primary antibody. 
Phenformin does not 
detectably alter membrane 
expression of CFTR. 
consistent with a selective change in R domain structure after PKA phosphorylation55,116. 
Correspondingly, Figure 2C reveals that PKA and AMPK dependent phosphorylation of the R 
domain created distinct peptide patterns, as described below in detail.  
The combined biochemical and physiological data shown below suggest a complex relationship 
between the PKA and AMPK driven phosphorylation of the R domain. To test this we undertook 
phospho-peptide mapping of the AMPK and PKA dependent phosphorylation of the R domain.   
 
In such experiments, it must be remembered that the interpretation rests on dramatic changes in 
phosphorylation because it is not possible to match exactly the conditions that might pertain in 
vivo.  First, we tested the effects of each kinase separately and found only two major 
phosphopeptide spots with AMPK but 4 phosphopeptide spots with PKA (Figure 2C, left 
uppermost panel pair). Next, we added the kinases sequentially in an attempt to mimic the 
physiological protocols used in the oocytes to stimulate or inhibit CFTR ion transport. These 
experiments were undertaken using unlabelled ATP in each first kinase run. To ease 
interpretation, we washed out residual kinase between runs to prevent any spill-over effects or 
kinase-kinase interactions (Figure 2C, lower panels). First, note the remarkable similarity 
between AMPK first, PKA second when compared to PKA alone (compare upper right with lower 
left in panel 2C). We conclude that AMPK (as first cold-label) cannot abrogate the subsequent 4-
spot ‘hot’ PKA-mediated pattern. AMPK when added second, cannot generate the expected two 
spot pattern observed with AMPK alone (Fig 2C lower right compared to upper left) suggesting 
either inaccessibility of the necessary site(s) based on the gel shift data (Figure 2B upper panel) 
that was either suggestive of a structural alteration or the unknown effects of some other 
phosphorylated site. Thus in vitro rank order matters for these kinases where specific site(s) on 
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the R domain labeling is concerned. We interpret these data to imply that a selective, major 
(>80%) reduction in R domain phosphorylation occurs when the S768 OH group is no longer 
available for phosphorylation which could either mean that this is a key AMPK site by itself or 
that S768 is ‘permissive’ i.e. is involved in docking/orienting AMPK or, alternatively is required 
for labeling some other site on CFTR. 
Next we tried to explore the different roles of the two serines with respect to AMPK but found 
that attempts to recreate the wild type pattern of spots in the presence of serine mutated R 
domain always showed a profound loss of label incorporation at short incubation times despite 
identical R domain protein loading suggesting that these two serines were the major R domain 
targets for AMPK. We therefore used prolonged incubation times to maximize the counts and 
these data are shown in Figure 2D. It is clear that S768A (lower left panel) has a more profound 
inhibitory effect on R domain phosphorylation compared to S737A (upper right) given that all 
these experiments were run simultaneously with similar concentrations of R domain protein and 
kinase, and each  imaged for identical lengths of time. Broadly, prolonged incubation that 
previously created two major spots found with AMPK alone was now supplemented by multiple 
small spots that almost disappeared after S768A mutation, but much less so after S737A 
mutation (Figure 2D, compare lower two panels with upper). Once again the critical role of S768 
is reiterated relative to S737. 
When expressed in oocytes, CFTR bearing the R domain mutants S737A and S768A as well as 
the double mutant S737A/S768A (Figure 4A) produced dramatically enhanced conductances 
(S768A> S737A; Fig 4B) upon stimulation with forskolin (2 µM) and IBMX (1 mM). In contrast, 
the S768D mutation, mimicking phosphorylation at S768, produced a whole cell conductance 
that was significantly smaller than even wtCFTR (note that conductance not lowered with 
S737D; see also Figure 4D for phenformin sensitivity of these mutants).  The large Cl- 
conductances generated by S737A/S768A were inhibited by 5 µM of the specific chloride 
channel blocker CFTRinh-172 (Figure 4C), or alternatively, the PKA inhibitor KT5720 and Cl- 
replacement by gluconate (not shown). Once again the differential roles of these two serines 
were observed because the conductance observed with S737A was almost 100 µS lower than 
that found with S768A. Furthermore, there remained a non-significant but interesting trend 
towards the retention of either inhibition or stimulation (with phenformin and compound C 
respectively) with the S737A but not with the S768A (compare second and third panels of Figure 
4D with the corresponding wild type result in the first panel of the figure). Overall the data 
suggest that S737A, S768A and the double mutant S737A/S768A were no longer sensitive to 
36  Mechanistic Insight into Control of CFTR by AMPK 
 
Figure 4:  Effects of AMPK on wtCFTR and R domain mutants. A) Whole cell currents activated by 
IBMX (1 mM) and forskolin (2 µM) in wtCFTR and S737A/S768A-CFTR expressing oocytes. B) 
Summary of whole cell conductances generated by wtCFTR and different CFTR-mutants. C) Summary 
of the whole cell conductance activated by S737A/S768A-CFTR and inhibition by the CFTR blocker 
CFTRinh172. D) Summary of CFTR whole cell conductances generated by wtCFTR and different CFTR-
mutants, and effects of phenformin and compound C. Membrane currents were measured by voltage 
clamping in intervals from -60 to +40 mV, in steps of 10 mV. ∗ significant difference when compared to 
control. # significant difference when compared to wtCFTR. Data are shown as mean ± SEM, (number 
of experiments). 
stimulation or inhibition of AMPK indicating that phosphorylation at both serines is required 
(Figure 4D, middle panels). In contrast the residual CFTR conductances generated by S768D 
(but not S737D) were not only further inhibited by phenformin, but neither phospho-mimic mutant 
could be augmented by the AMPK inhibitor compound C. Thus the presence of a fixed negative 
charge at S768 maintains sensitivity to AMPK-mediated inhibition whereas this is lost when 
S737 has a similar negative charge. Yet, unlike wild type CFTR, neither D mutant is able to 
enhance their conductance when AMPK is inhibited (Figure 4D).  Thus negative charge at serine 
768 is discriminant between inhibition and activation by AMPK. 
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Figure 5: S737A/S768A-CFTR generates a baseline conductance. A) Effect of extracellular Cl- 
replacement by gluconate (glcn) on whole cell currents generated by wtCFTR, S768A-CFTR and 
S737A/S768A-CFTR in the absence of IBMX and forskolin. B) Summary of the corresponding whole cell 
conductances. C) Summary of the whole cell conductances generated by wtCFTR and S737A/S768A-
CFTR in the absence of stimulation with IBMX and forskolin and effects of phenformin, compound C and 
CFTRinh172. D,E) Baseline whole cell conductances generated by wild type CFTR (D) and S737A/S768A-
CFTR (E) and effects of compound C and the PKA inhibitor KT520. Membrane currents were measured 
by voltage clamping in intervals from -60 to +40 mV, in steps of 10 mV. ∗ significant difference when 
compared to control. Data are shown as mean ± SEM, (number of experiments). 
In contrast to wtCFTR the CFTR mutants S737A (not shown), S768A and S737A/S768A 
produced a high Cl- conductance under basal conditions, i.e. in the absence of IBMX and 
forskolin (Figure 5A,B). Enhanced basal conductance of the mutants (but not wild type) was 
inhibited by replacement of extracellular Cl- with gluconate (Figure 5B). Yet both the basal 
conductance of the mutants and the basal conductance of wtCFTR after compound C were 
blocked by CFTRinh-172 (Figure 5C, rightmost columns) suggesting both were indeed CFTR 
mediated. As described above for activated whole cell Cl- conductance, the enhanced baseline 
conductance exhibited by these mutants was also insensitive to phenformin and compound C, 
consistent with a loss of AMPK sensitivity (Figure 5C).  Moreover, the PKA inhibitor KT5720 (50 
µM) inhibited this enhanced baseline CFTR conductance generated by S737A/S768A 
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irrespective of the presence of compound C (Figure 5E). In contrast, KT5720 did not affect the 
very low conductance produced by unstimulated wtCFTR (Figure 5D), suggesting this was PKA-
independent (note also the corresponding insensitivity to gluconate replacement, Fig 5A,B left 
panels). We interpret this finding to suggest that the sensitivity of S737A/S768A-CFTR towards 
PKA inhibition is retained which implies that PKA is now active after the loss of AMPK sensitivity. 
The combined data posit a feedback loop between PKA and AMPK.  
Physiological role of AMPK-regulation: We further examined the conditions under which 
regulation of CFTR by AMPK occurs. To that end we gradually increased CFTR activity by 
stimulating wtCFTR expressing oocytes either leaving phosphodiesterases intact or by inhibiting 
them differentially (left to right Fig 6A)  as follows i) 2 µM forskolin (21 ± 3.7 µS), ii) 2 µM 
forskolin and 1 mM IBMX (61 ± 6.8 µS), or iii) 2 µM forskolin, 5 mM IBMX and 3 mM 8Br--cAMP 
(120 ± 9.8 µS), in the presence or absence of compound C to detect inhibitory effects of AMPK 
(Figure 6A). Interestingly, at increased PKA-stimulation, the compound C effect was reduced 
and was undetectable at maximal stimulation, confirming interference between phosphorylation 
by AMPK and by PKA (upper panel). Thus the data suggest that one physiological role of the 
tonic basal AMPK activity may be to keep the CFTR channel shut, as evidenced by the rise in 
basal conductance with compound C alone in the absence of secretagogue stimulation (Figure 
5), rather than limiting excessive activation as suggested previously. The initial recovery from 
PKA-stimulation was equal in S737A/S768A (1.1 ± 0.3 µS/min) and wtCFTR (1.1 ± 0.1 µS/min) 
(Figure 6C), but was enhanced in ooctyes coexpressing kinase-dead AMPKα1-K45R (2.8 ± 0.4 
µS/min), while overexpression of wtAMPKα1β1γ1 literally eliminated CFTR currents (Figure 6B). 
In these experiments we stimulated oocytes with only 20 µmol/l forskolin that creates a transient 
pulse of cAMP capable of being degraded by phosphodiesterases. Although AMPK largely 
antagonizes activation of CFTR, the mutated serines S737A and S768A do not seem to 
influence the recovery time from forskolin stimulation. AMP may be generated in close proximity 
of CFTR, probably by local phosphodiesterases. It has been shown that PDE4D is translocated 
to CFTR via the PDZ protein Shank2 that binds to the C-terminal PDZ binding domain of 
CFTR62. Thus negative regulation of CFTR via Shank2 occurs in competition with positive 
regulation by other PDZ proteins, such as NHERF1, which translocates protein kinase A close to 
the R domain117. We eliminated the PDZ binding domain of CFTR (E1474X-CFTR) and 
gradually increased stimulation of the oocytes as shown in Figure 6D. As expected, we found 
that stimulation with 3 mM 8Br--cAMP (which acts both through stimulation of PKA and by 
blocking PDE activity) was able by itself to activate wtCFTR maximally, i.e. no further activation   
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Figure 6: Functional role of AMPK-regulation of CFTR. A) Activation of CFTR whole cell 
conductance by stimulation with 20 µM forskolin (left column pair, raw baseline data in lower panel), 1 
mM IBMX 80 µM forskolin (middle column) and 5 mM IBMX, 2 µM forskolin and 3 mM 8Br--cAMP (right 
column). Increase of CFTR whole cell conductance by compound C (80 µM) relative to CFTR-baseline 
conductance (upper panels). B) Inactivation of CFTR whole cell conductances in oocytes expressing 
CFTR, CFTR and AMPKα1β1γ1, or the catalytically dead mutant AMPKα1-K45R. C) Inactivation of 
conductances generated by wtCFTR and S737A/S768A-CFTR. D) CFTR whole cell conductances 
activated by 3 mM Br--cAMP, 3 mM Br--cAMP and 2 µM forskolin, or 3 mM Br--cAMP and 2 µM 
forskolin and 1 mM IBMX, and effects of compound C. E) Activation of CFTR by forskolin (2 µM) and 
additional stimulation by rolipram (50 µM), dipyridamol (80 µM) and IBMX (1 mM). Membrane currents 
were measured by voltage clamping in intervals from -60 to +40 mV, in steps of 10 mV. ∗ significant 
difference when compared to control. # significant difference when compared to wtCFTR. Data are 
shown as mean ± SEM, (number of experiments). 
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by additional stimulation with forskolin (2 µM) or IBMX (5 mM). Also, consistent with Figure 6A, 
right panel, inhibition of AMPK by compound C had no further enhancing effects on wtCFTR 
activity. In marked contrast 3 mM 8Br--cAMP alone was unable   to promote full activation of 
E1474X-CFTR but instead required co-stimulation by 8Br- cAMP, forskolin and IBMX, and 
compound C further augmented whole cell conductance (Figure 6D) suggesting AMPK 
sensitivity was retained by this mutant. The data suggest that translocation of signaling 
cascades in close proximity to CFTR might be required for graded regulation of CFTR. This 
notion was supported by injection of oocytes with AMP to reach a final cytosolic concentration of 
1 mM which did not inhibit CFTR. Although diffusion barriers for AMP could exist within the 
oocyte, the result suggests that global cytosolic AMP increase in unlikely to influence the 
membrane compartment. Furthermore, the inhibitors of the CFTR-specific PDE4 and PDE5 
rolipram and dipyridamole also augmented CFTR whole cell conductance suggesting that 
CFTR-localized phosphodiesterase activity may generate environmental AMP that enhances 
AMPK activity in close proximity of CFTR (Figure 6E). 
 
DISCUSSION 
Regulation of CFTR by AMPK: The present results demonstrate that baseline CFTR activity is 
tonically inhibited by high baseline AMPK activity but after PKA stimulation, AMPK only has a 
modest inhibitory effect on wild type CFTR. This might explain why data reported previously by 
Hallows and colleagues found only modest inhibition of pre-activated CFTR by post-activation of 
AMPK in Xenopus oocytes38. It is not widely appreciated outside the specialist kinase field that 
AMPK has a substantial and constitutive baseline activity in most tissues that is further 
stimulated by increments in the intracellular AMP/ATP ratio or pharmacological activation by 
drugs such as phenformin. Additionally, independent regulation by the calmodulin dependent 
kinase (CAMKK) has been shown previously118,119. It may be of relevance to our findings in 
oocytes that PKA was shown to inhibit AMPK activity by attenuating phosphorylation through 
upstream calcium/calmodulin dependent protein kinase120. Thus multisite phosphorylation 
controls AMPK activity and the cross-talk between PKA and AMPK may be relevant for the 
competitive regulation of CFTR by PKA and AMPK as demonstrated in the present paper. 
 AMPK phosphorylates the R-domain: We provide biochemical and electro-physiological data 
consistent with the hypothesis that AMPK-regulation involves two so called inhibitory PKA sites 
at S737 and S768 in the R-domain53,55. Correspondingly, but with the caveat that 
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phosphorylation of these serines happens at a biochemical level in vitro, we nevertheless 
observe a dramatic difference in the consequent pattern of phosphopeptides in the R domain 
when the rank order in which these kinases are applied is reversed (as shown in Figure 2) and 
note the differential effect of serine 768 in this respect. Binding of the α1-subunit of AMPK to the 
residues 1420–1457 in the C-terminus of CFTR seems to be essential for AMPK regulation of 
CFTR, as demonstrated by a failure of AMPK to inhibit CFTR in the absence of this binding 
motif38. The present results (Figure 3) also confirm those of previous studies in that they 
demonstrate inhibition of the open probability of CFTR by phosphorylation through AMPK, rather 
than effects on membrane expression35. AMPK’s actions are complex as this kinase regulates a 
number of transport proteins involved in secretion or absorption of electrolytes in epithelia. Thus 
epithelial Na+ channels97,121,122, the renal NKCC2123,124, CFTR35,38,103 and probably the secretory 
Na+/2Cl-/K+-cotransporter (NKCC1)124 can all be controlled by AMPK. Regulation occurs either 
indirectly, as in the case of epithelial Na+ channels (ENaC), or directly through AMPK-
phosphorylation as for CFTR, NKCC2 and probably NKCC1. AMPK is inhibitory on the ion 
transport generated by ENaC, CFTR, and NKCC1, however, the functional impact of AMPK on 
NKCC2 still remains to be determined124. It is also of interest that AMPK activation reduces 
inflammation in airway epithelial cells of CF patients36 and we note that AMPK and CFTR are co-
localized at the apical membrane in such tissues. 
CFTR is the only ABC transporter that has a regulatory (R) domain, containing multiple 
consensus sites for phosphorylation by PKA and PKC13. Phosphorylation of the R-domain by 
PKA is a prerequisite, but is not sufficient to gate the Cl- channels. Additional binding of ATP to 
both nucleotide binding domains is required to open the channel45,116. Phosphorylation at 
individual PKA sites has additive effects on the open probability of CFTR, and so 
phosphorylation of the individual serines occurs independently. Moreover, none of the PKA sites 
is absolutely necessary for activation of CFTR53. Notably, two of the PKA consensus sites (S737 
and S768) have been suggested to be inhibitory since elimination of these sites largely 
augments activation of CFTR53,55. Our present results suggest that it might be AMPK rather than 
PKA that is phosphorylating S737 and S768 under baseline conditions, i.e. in the absence of 
any stimulation by secretagogues. This novel idea is consistent with the inhibition of CFTR in the 
presence of D mutants at one of these sites, namely S768. 
Physiological relevance: It has been assumed that the inhibitory effects mediated by S737 and 
S768 can be overcome by stimulation with super-maximal concentrations of IBMX53. The 
present data clearly demonstrate that this is not the case: Even maximal stimulation of wtCFTR 
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with a cocktail of 8-Br--cAMP, IBMX and forskolin does not produce the same high level of 
conductance as S737A-CFTR or S768A-CFTR. A detailed single channel analysis by the 
Gadsby group arrived at a related conclusion that early phosphorylation of Ser 768 in CFTR 
impairs subsequent phosphorylation of stimulatory R-domain serines. They further postulated 
that the observed reduced sensitivity to activation by PKA imparted by Ser 768 might ensure 
activation of CFTR during strong stimulation but attenuating responses to weak signals55. 
Further data will be needed to test this idea but our phosphorylation data concur to the extent 
that they demonstrate that a complex interaction occurs through this critical serine. 
In the present study we found that AMPK phosphorylation of S737 and S768 does not appear to 
affect activation or deactivation kinetics of CFTR. However, our data strongly suggest that 
increasing PKA activity ‘competes out’ AMPK sensitivity, so that only PKA will control CFTR. An 
antagonistic regulation of CFTR by AMPK under control conditions will guarantee that the 
channel is kept closed in the absence of secretagogues. Overall our data are consistent with the 
notion that AMPK activity acts as a ‘biological rheostat’ towards CFTR. As some epithelial 
tissues such as the sweat duct epithelium and the submucosal gland epithelium show a high 
baseline CFTR activity125,126, it will be interesting to examine if these tissues lack of AMPKα1-
expression or have otherwise a reduced AMPK-activity or sensitivity towards CFTR. 
CFTR localized AMPK: Around 40% of resting energy expenditure in humans is used to control 
ion gradients across cells and crosstalk between transport and metabolism has been proposed 
that would adjust transport activity to the cellular energy supply96. CFTR is ideally localized to 
perform such a sensing role because it lies in a macromolecular complex together with 
receptors, adenylate cyclase, kinases, scaffolding proteins and phosphodiesterases. Thus CFTR 
can integrate various proteins to a ‘channelsome’, a functional unit that operates independently 
of other cellular compartments59. Receptor mediated compartmental activation of CFTR is 
probably disconnected from the cytosol, i.e. intracellular signaling by cAMP is spatially restricted 
and compartmentalized (reviewed in127,128). In this model, regulation of CFTR is predicted to 
occur without any detectable changes in cytosolic second messenger concentration, because 
CFTR is intimately connected to signaling elicited by stimulation of A2B adenosine and ß2 
adrenergic receptors129,130. Moreover, type 2 lysophosphatidic acid (LPA) receptors also form 
macromolecular complexes with CFTR that are mediated through a PDZ scaffolding protein 
(NHERF2). In contrast to adenosine and ß2 adrenergic stimulation, LPA inhibits CFTR through a 
LPA2 receptor mediated Gi pathway131. Thus compartmentalized receptor-CFTR coupling 
appears to be critical for a rapid and specific signal transduction from the receptor to the 
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channel. PDEs provide the means to avoid spreading of intracellular signals by degrading 
cAMP, and therefore play a vital role in shaping intracellular gradients of the second 
messenger45. Particularly PDE4D, which couples to CFTR via the PDZ adaptor Shank2, 
precludes cAMP/PKA signals62. However, not only PDEs but also other mechanisms contribute 
to compartmentalization such as the cAMP transporter MRP4. This multidrug resistance protein 
also belongs to the large family of ABC-transporters, and physically couples to CFTR via 
PDZK1132. By providing an efflux pathway for cAMP, it constitutes an additional way of regulating 
cAMP levels in a microdomain underneath the surface membrane. In the present study both the 
PDE4 inhibitor rolipram and the PDE5 inhibitor dipyridamole augmented CFTR activity, 
confirming that both PDE-subtypes degrade cAMP locally, i.e. in close proximity to CFTR. In 
analogy to the well anticipated localized cAMP signaling, we hypothesize that local generation of 
AMP, perhaps in some instances generated by the very same phosphodiesterases from cAMP, 
controls the activity of AMPK, rather than global cytosolic changes in the ATP/AMP ratio. Thus 
AMPK may serve as a local controller of CFTR activity rather than coupling global cellular 
metabolism to CFTR’s transport activity96. The data show that enhanced CFTR activity can be 
observed by mutating critical serines that negate inhibition by AMPK, such as serine 768. Our 
failure to reverse the gating defects in two common disease causing mutants (G551D and 
F508delCFTR) suggests that their mechanism of dysfunction is not due to an overactive AMPK 
but further work will have to establish whether inhibition of AMPK might be a therapeutic option 
in other mutations.   
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CHAPTER 4.  
 
Metformin Treatment of Diabetes Mellitus Increases the Risk for 
Pancreatitis in Patients Bearing the CFTR-mutation S573C 
ABSTRACT 
Metformin use in diabetes can cause acidosis and might be linked to pancreatitis. Here, we 
mechanistically focus on this relationship via a point mutation in the cystic fibrosis 
transmembrane conductance regulator (CFTR; ABCC7). CFTR is an ATP-hydrolyzing, 
cAMP/PKA-activated anion channel regulating pancreatic bicarbonate/chloride secretion across 
duct-facing apical membranes in epithelia. CFTR has two nucleotide binding domains (NBD1/2) 
which clamp two ATP molecules across their opposed, inverted interfacial surfaces which 
generates anion-conductance after ATP hydrolysis. Notably, CFTR mutations not causal for 
classical cystic fibrosis segregate with unexplained pancreatitis and one of these lies in NBD1 
near its ATP-clamp (S573C; close to the Walker B aspartate D572). We recently showed that 
after raising [cAMP], wt-CFTR chloride-conductance, when expressed in Xenopus oocytes, 
remains elevated despite the presence of metformin. Yet here, we find that S573C-CFTR 
manifests a metformin-inhibitable whole cell chloride-conductance after cAMP elevation. In the 
absence of metformin, cAMP-activated S573C-CFTR also displays a reduced anion-
conductance relative to wt-CFTR. Furthermore, intra-oocyte acidification inhibited wt-CFTR and 
abolished S573C-CFTR conductance. We conclude that defective S573C-CFTR remains both 
poorly conducting and inhibited by metformin and intracellular acidosis. This might explain the 
propensity to pancreatitis with this rare CF mutation. 
 
Key words: Cystic fibrosis transmembrane conductance regulator, CFTR, AMP, PKA, AMP-
activated protein kinase, S573C, Pancreatitis, Metformin, Pancreas, Chloride secretion.  
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INTRODUCTION 
Pancreatitis arises from a complex amalgam of genetic and environmental factors. In one 
instance, pancreatitis has an onset during fetal life in the common inherited disease, cystic 
fibrosis (CF) that affects about 1 in 4000 babies in the developed world. CF is caused by 
mutations in a phosphorylation and ATP-regulated chloride channel, the cystic fibrosis 
transmembrane-conductance regulator (CFTR). Even before CFTR was cloned two decades 
ago, the classical form of CF was recognized as a disease associated with low volumes of 
pancreatic fluid secretion containing less bicarbonate compared to non-CF pancreatic juice. 
Although the role of CFTR in bicarbonate secretion by CFTR in the pancreatic duct is not fully 
elucidated133, it is now almost axiomatic that CFTR can conduct anions other than chloride and 
HCO3- is foremost amongst such candidates (another is glutathione). Bicarbonate transport via 
CFTR recycles with luminal Cl- across the apical membrane of pancreatic duct cells and is 
therefore functionally coupled to luminal anion exchangers in charge of net HCO3- flux. 
In fact CFTR may physically interact with two bicarbonate exchangers SLC26A6 and DRA (down 
regulated in adenoma)9,134,135. Activation of CFTR by DRA is facilitated by the C terminus of 
CFTR where PDZ ligands can interact through a conserved motif whereas the binding of the 
SLC26T STAS domain occurs through the CFTR regulatory (R) domain. The R domain is unique 
to CFTR when compared to other members of the ABC family and is the site of multiple 
regulation by protein kinases such as PKA (cAMP-dependent), PKC (lipid and calcium 
regulated) and AMP-activated kinase (a metabolic regulator). Binding of the STAS and R 
domains was shown to be regulated by PKA-mediated phosphorylation of the R domain136,137 
which we and others find to dramatically alter its structure (as judged by NMR and gel shift 
analysis) after phosphorylation by PKA. Thus R domain plasticity, associated changes in CFTR 
function and regulated HCO3- secretion appear to be tightly coupled. These ideas underpin 
classical Cystic fibrosis (CF) which is also characterized by a chronic lung disease that follows 
airway obstruction and chronic infection by many bacteria but particularly Pseudomonas 
aeruginosa. Other features include elevated sweat electrolyte concentrations, male infertility and 
almost always in such cases, there exists a severe degree of pancreatic insufficiency that 
follows the precipitation of pancreatic enzymes within the pancreas itself. Precipitation and 
premature activation lead to pancreatic autodigestion due to a failure of duct fluid secretion138. 
Moreover, the variability in repeat numbers of certain intronic elements at exon-intron 
boundaries CFTR gene characterized by the 5T poly-pyrimidine tract genotype have also been 
Metformin Treatment of Diabetes Mellitus Increases the Risk  
for Pancreatitis in Patients Bearing the CFTR-mutation S573C 47 
 
found to be associated with chronic pancreatitis139-143. This complexity is exacerbated by a wider 
spectrum of non-classical CF that is ‘organ-confined’ affecting one or more organs but sparing 
the lung. Thus an emerging view is that it is possible for a patient to have CF of the organs and 
not CF as a whole. Here we expand this theme by focusing on one mutation in CFTR that lies 
close to one of the Walker B motifs involved in ATP binding to the first nucleotide binding 
domains of CFTR. 
CFTR is regulated by many protein kinases and the adenosine monophosphate activated 
protein kinase (AMPK) is known to inhibit CFTR function38,111. AMPK is a ubiquitous Ser/Thr 
kinase with a substantial basal constitutive activity independent of AMP (hence the designation 
as AMP-activated rather than the AMP-regulated) and is the downstream effector of a cascade 
that is sensitive towards cellular energy. Upon ATP depletion, the substantial basal activity of 
AMPK is further activated by a rise in AMP which then stimulates catabolic pathways that 
ultimately lead to restoration of ATP production. In AMP-activated mode, AMPK also 
downregulates anabolic pathways that consume ATP, by direct phosphorylation of metabolic 
enzymes or by regulating gene expression39. Biguanidine compounds such as metformin (or the 
more potent but clinically toxic phenformin) activate AMPK in part by inhibiting complex I of the 
respiratory chain but additional mechanisms may also be operant41,107. Metformin is widely used 
in the clinical treatment of type II diabetes. Phenformin and metformin both promote insulin-
stimulated glucose uptake in muscle tissues and lower hepatic glucose output. Metformin slightly 
increases the risks of lactic acidosis (much more so with phenformin) and patients using this 
compound can develop pancreatitis secondary to metformin poisoning, or at therapeutic 
metformin doses when a patient presents with renal failure43,44. Phenformin has been withdrawn 
from clinical use due the high incidence of lactic acidosis and it was replaced by metformin, 
which still has some risk of lactic acidosis and pancreatitis43,107.  
CFTR binds two ATP molecules using a sandwich structure consisting of nucleotide binding 
domains (NBDs) 1 and 2.  We investigated the S573C point mutation that lies within the first 
nucleotide binding domain of CFTR adjacent to the Walker B aspartate at D572. S573C appears 
not to induce classical CF but instead segregates with pancreatitis of unknown etiology88,89. We 
tested the hypothesis that this was merely a chance finding by investigating S573C-CFTR 
function.  Should we find no obvious change in CFTR function compared to wild type then we 
would have to conclude that the mutation was just a polymorphic variant of no particular 
consequence with just a random association with pancreatic failure. We find that this is not the 
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case and present a testable hypothesis about the means by which this mutant CFTR might 
induce pancreatitis. We speculated that the presence of the CFTR gene variant S573C in non-
CF diabetes patients renders them more susceptible towards the development of pancreatitis 
and tested the potential role of metformin. We therefore examined the function of S573C and 
other point mutants of CFTR at this site by overexpression in Xenopus oocytes. The data 
indicate a lower channel activity of S573C-CFTR with a higher sensitivity towards metformin-
induced closure. Impaired Cl- channel function and regulatory function of S573C-CFTR may 
explain the higher incidence of this mutant in patients with pancreatitis. 
 
MATERIALS AND METHODS 
cRNAs for CFTR and double electrode voltage clamp: Oocytes were injected with cRNA (10 ng, 
47 nl double-distilled water) encoding wtCFTR, S573C-CFTR, and S573A-CFTR. All mutants 
were generated by PCR and correct sequences were confirmed by restriction digest and by 
sequencing. Water injected oocytes served as controls. 2 - 4 days after injection, oocytes were 
impaled with two electrodes (Clark Instruments Ltd, Salisbury, UK), which had a resistances of < 
1 MΩ when filled with 2.7 mol/l KCI. Using two bath electrodes and a virtual-ground head stage, 
the voltage drop across the serial resistance was effectively zero. Membrane currents were 
measured by voltage clamping (oocyte clamp amplifier, Warner Instruments LLC, Hamden CT) 
in intervals from -60 to +40 mV, in steps of 10 mV, each 1 s. The bath was continuously 
perfused at a rate of 5 ml/min. All experiments were conducted at room temperature (22 °C). 
Materials and statistical analysis: All compounds used were of highest available grade of purity 
and were purchase from SIGMA or Calbiochem. Student’s t-test was used for statistical analysis. 
A p value of <0.05 was regarded as significant. 
 
RESULTS 
S573C attenuates CFTR whole cell Cl- conductance and is inhibited by metformin: Because 
S573C-CFTR has been found in patients with pancreatitis, we examined the ability of both 
wtCFTR and S573C-CFTR to generate Cl- currents by maximal stimulation of Xenopus oocytes 
with IBMX (1 mM) and forskolin (2 µM). Under these conditions which elevate cAMP and 
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Figure 1:  S573C attenuates 
CFTR whole cell Cl- 
conductance. Current 
recordings obtained in Xenopus 
oocytes expressing wt-CFTR (A) 
or S573C-CFTR (B) showing 
activation of whole cell Cl- 
currents by stimulation with IBMX 
(1 mM) and forskolin (2 µM). 
Summaries of whole cell 
conductances under control 
conditions and after stimulation 
with I/F (G) (C,D). Summaries of 
whole cell conductances 
activated by IBMX and forskolin 
(GI/F) in ooctyes expressing wt-
CFTR (E) and S573C-CFTR (F), 
and effects of the activators of 
AMPK metformin (Met; 2 mM) 
and phenformin (Phen; 1 mM) or 
the AMPK-inhibitor compound C 
(comp C; 80 µM). Mean ± SEM, 
(n) = number of cells measured. 
*significant increase in whole cell 
conductance (paired t-test). 
 
activate PKA, whole cell currents and conductances produced by S573C-CFTR were reduced 
(~20%) when compared to those produced by wt-CFTR (Figure 1A-D). AMP-activated protein 
kinase (AMPK) has been shown previously to inhibit CFTR and to be relevant in vivo35,38,111,144. 
The biguanide metformin that is used for treatment of type 2 diabetes mellitus, is also known to 
activate AMPK and therefore may inhibit CFTR, similarly to the more potent phenformin. We 
examined the effect of 2 mM metformin on CFTR-conductance and compared the effect with that 
of phenformin (1 mM). Metformin only inhibited S573C-CFTR but not wt-CFTR (compare second 
bars in Figure 1 E,F), in contrast to the more potent activator of AMPK, phenformin that inhibited 
both S573C-CFTR and wt-CFTR (Figure 1E,F). Thus mutation of serine 573 to a close analogue 
merely bearing an S replacing an oxygen in an alcoholic side chain reduces CFTR-conductance 
and appears to enhance both sensitivity towards AMPK-induced closure and conversely, this 
mutant fails to almost double CFTR conductance after pharmacological inhibition of AMPK using 
compound C (Figure 1E,F).  
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Figure 2: Metformin inhibits S573C-CFTR but not wt-CFTR. Current recordings obtained in a 
Xenopus oocyte expressing wt-CFTR (A) or S573C-CFTR (B) showing activation of whole cell Cl- 
currents by stimulation with only forskolin (20 µM). Summaries of the whole cell conductances under 
control conditions and after stimulation with I/F (G) (C,D). Summaries of the ration of whole cell 
conductances activated in the presence of metformin (500 µM) or under control conditions in oocytes 
expressing wt-CFTR and S573C-CFTR (E). Mean ± SEM, (n) = number of cells measured. *significant 
increase in whole cell conductance (paired t-test). # significant difference when compared to wt-CFTR. 
 
We demonstrated recently that CFTR is more susceptible towards inhibition by AMPK at lower 
cAMP-induced activation levels111. Therefore we stimulated oocytes with forskolin alone (20 µM), 
which caused about 10 % of maximal activation of CFTR (Figure 2A-D). Under these conditions 
it became quite obvious that S573C-CFTR has a reduced Cl- conductance compared to wtCFTR 
(Figure 2C,D) and that 500 µM metformin did not inhibit wtCFTR and yet inhibited S573C-CFTR 
by about 25% (Figure 2E), thus confirming the enhanced sensitivity of S573C-CFTR for 
inhibition by metformin.  
Phosphorylation of NBD1 is enhanced by the mutation S573A: Previously we found that two 
serines in the regulatory (R) domain of CFTR, S737 and S768, formerly identified as inhibitory 
PKA sites, are phosphorylated by AMPK and are the residues essential for inhibition by 
AMPK111. Since S573 is located in the first nucleotide binding domain (NBD1) of CFTR and 
because inhibition by the AMPK-activator metformin is enhanced for S573-CFTR, the present 
results suggest that NBD1 may contribute to regulation of CFTR by AMPK. We therefore 
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Figure 3: Phosphorylation and activation of S573A-CFTR. Phosphorylation by AMPK of the first 
nucleotide binding domains (NBD1) of wtCFTR and S573A-CFTR (A). Summary of the whole cell 
conductances activated by IBMX (1 mM) and forskolin (20 µM) (GI/F) obtained in Xenopus oocyte 
expressing S573A-CFTR (B) or S573A-CFTR (C) and effects of activators (metformin, phenformin) or an 
inhibitor (compound C) of AMPK. Mean ± SEM, (n) = number of cells measured. *significant effects on 
whole cell conductance (paired t-test).  
examined whether eliminating the serine at position 573, or a specific exchange of serine by 
cysteine is reducing CFTR activity. We investigated a S573A-CFTR mutant and found that it 
behaved like wild type and critically, has lost its inhibitory metformin sensitivity when stimulated 
by a rise in cAMP (Figure 3B).  This suggested that CFTR is able to discriminate between a 
methylene group on the side chain at position S573 bearing either an OH (wild type) or the 
bulkier SH group. We interpreted this data to suggest that the S573C defect might lie 
downstream of AMPK due to perturbation of the milieu around either the adjacent Walker B 
aspartate (for example at D572) or near another local cysteine, as suggested by Chen et al. 
during their pH studies145. We were particularly interested in the role of pH in this process 
because Sheppard and colleagues had found that this very same region might be involved in pH 
sensing (Chen et al)145. To rule out a direct effect of AMPK on this serine, we examined 
phosphorylation of isolated NBD1 in vitro and found that AMPK indeed phosphorylated this 
domain of CFTR as expected (Figure 3A). We mutated serine 573 to an alanine and found that 
elimination of this potential phosphorylation site did not abolish phosphorylation of NBD1 by 
AMPK (Figure 3A). These results were consistent with existence of other phosphorylation sites 
for AMPK in NBD1, which are different from serine 573. Although in vitro phosphorylation data 
do not allow for quantitative assessment, it appears that AMPK-phosphorylation of the S573A 
mutant was somewhat augmented but this may equally be an artifact caused by slight 
differences relative amounts of protein. This was not taken further here because mutation at 
S573 did not have a dramatic effect on phosphorylation by AMPK compared to other CFTR sites 
(S768 for example) we had previously encountered leading us to concentrate on pH effects. 
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Figure 4: Extracellular 
acidification does not 
affect control oocytes. 
Current recording obtained 
in a non-injected Xenopus 
oocyte indicating lack of 
effects of forskolin or 
extracellular pH 5.5 (A). 
Summary of whole cell 
conductances obtained in 
control oocytes in the 
absence or presence of 
extracellular acidosis or 
stimulation with forskolin (B). 
Summary of the whole cell 
conductances generated by 
wt-CFTR, S573C-CFTR and 
S573A-CFTR when 
activated by forskolin (20 
µM) in the presence of pH 
5.5, and effects of metformin 
(500 µM) (C). Mean ± SEM, 
(n) = number of cells 
measured. 
 
Acidification equally inhibits wtCFTR, S573A-CFTR and S573C-CFTR: Lactic acidosis with the 
consequence of pancreatitis may be caused by the use of antidiabetic biguanide drugs such as 
phenformin or metformin43,44,146,147. We wondered whether change in external pH and in 
particular acidosis may be an additional factor that inhibits the function of wild type CFTR. Also, 
the inhibitory effect of metformin may be potentiated in the presence of extracellular acidosis 
which could explain the pancreatitis observed upon treatment with biguanide drugs and lactic 
acidosis43. Water-injected control oocytes remained completely unaffected by extracellular 
acidification (Figure 4A,B). Moreover extracellular pH does not per se affect ion currents of 
Xenopus oocytes expressing CFTR (data not shown). Surprisingly, metformin (500 µM), when 
applied in the presence of acidic pH (pH 5.5), did not inhibit forskolin (20 µM) activated Cl- 
currents, generated by wt-CFTR, S573C-CFTR, or S573A-CFTR (Figure 4C). Thus the S573C 
CFTR which had previously retained metformin-induced inhibition despite the presence of 
forskolin and IBMX, had now ‘become wild type’ just like S573A.  
 
Metformin Treatment of Diabetes Mellitus Increases the Risk  
for Pancreatitis in Patients Bearing the CFTR-mutation S573C 53 
 
 
We further tested whether intracellular acidification differentially affects whole cell currents 
produced by wt-CFTR, S573C-CFTR, or S573A-CFTR.  To that end oocytes were exposed to 
the protonophore carbonyl cyanide m-chloro phenylhydrazone (CCCP; 10 µM) at different 
extracellular pH ranging from pH 5.5 to pH 8.5. We observed regular activation of wt-CFTR and 
S573A-CFTR by forskolin (20 µM) in the presence of CCCP and at physiological pH (pH 7.5), 
while activation of S573C-CFTR was largely reduced (Figure 5A-C). Subsequent, acidification 
inhibited Cl- currents produced by wt-CFTR, S573C-CFTR, or S573A-CFTR, while subsequent 
alkalinization did not affect whole cell Cl- currents (Figure 5A-C). In fact acidosis completely 
inhibited S573C-CFTR currents. Taken together the present results are consistent with a model 
whereby the S573C-CFTR mutation predisposes to pancreatitis because it i) may sensitize 
Figure 5: Inhibition of wtCFTR, S573C-CFTR, and S573A-CFTR by intracellular acidosis. Current 
recordings obtained in a Xenopus oocyte expressing wt-CFTR (A), S573C-CFTR (B), or S573A-CFTR (C). 
Summary of the whole cell conductances under control conditions and after stimulation with forskolin (20 
µM), in the presence of CCCP at different extracellular pH. Acidification (pH 5.5, pH 6.5) but not 
alkalinization (pH 8.5) inhibits Cl- currents generated by wt-CFTR, S573C-CFTR and S573A-CFTR. 
Acidosis completely inhibited currents produced by S573C-CFTR and S573A-CFTR. (D-F). Mean ± SEM, 
(n) = number of cells measured. *significant increase in whole cell conductance (paired t-test). 
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CFTR towards inappropriate regulation by AMPK, ii) is inhibited by the therapeutic biguanide 
metformin and iii) is inhibited potently by acidification. 
 
DISCUSSION 
Pancreatitis is not a common complication during metformin therapy; however, there are clinical 
cases of pancreatitis associated with metformin treatment43. CFTR has a clear role in alkalinizing 
the pH of the pancreatic juice, thereby solubilizing secreted enzymes, neutralizing  acid chyme 
that is entering the duodenum and preventing premature activation of enzymes within the 
pancreatic duct135,148. Notably, fluid and HCO3- secretion occurs in a coordinated manner and it 
has been demonstrated recently that basolateral HCO3- entry via the Na+/HCO3- cotransporter, 
pNBC1, and exit at the luminal side by the CFTR/SLC26 transporter-complex is coordinated by 
the protein IRBIT (inositol-1,4,5-trisphosphate receptors binding protein released with IP3)136. 
This is discussed further and in depth elsewhere145 but our data suggest that near the site of 
ATP binding in NBD1, subtle alterations induced by and O-S group substitution next to the 
Walker B aspartate motif in NBD1 not only reduce the conductance of CFTR (as might be 
expected by a potential effect on ATP binding) but, unexpectedly, alter the ability of CFTR to 
respond to a step change in pH or metformin application. Moreover, functional CFTR is also 
essential for bicarbonate secretion in the small intestine149 and CFTR-dependent duodenal 
HCO3- secretion in the mouse colon is strictly dependent on colocalization of ß2-adrenergic 
receptors and CFTR and the function of the Na+/H+ exchanger regulatory factor, NHERF1150.  
The team of Argent and Gray found inhibition of CFTR Cl- currents in guinea pig pancreatic duct 
cells by extracellular HCO3- that may have clear implications for the current models of pancreatic 
ductal HCO3- secretion151. This may also be of clinical relevance, since a cystic fibrosis 
phenotype has been observed in a previously healthy adolescent presenting with metabolic 
alkalosis152. In contrast, CFTR does not seem to be regulated by extracellular pH, according to 
previous studies on isolated sweat ducts153. In contrast Reddy and coworkers found inhibition of 
phosphorylation by intracellular acidification, which might explain inhibition of CFTR currents by 
intracellular acidosis observed in the present study through interactions with other protein 
kinases153. The result of the present study pose challenging new questions with respect to the 
molecular mechanisms for predisposal of S573C towards AMPK-phosphorylation, the residues 
within NBD1 that are phosphorylated by AMPK, and how S573C within NBD1 affects pH 
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sensitivity of CFTR.  Despite these open questions, the currents results suggest caution when 
biguanide drugs are used in a cystic fibrosis patient or patients carrying one of the CFTR 
variants predisposing to pancreatitis. 
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CHAPTER 5.  
 
CFTR Induces Acid Sensing and H+ Activated Cl- Transport 
ABSTRACT 
The cystic fibrosis transmembrane conductance regulator (CFTR) produces a cAMP-dependent 
Cl- conductance of distinct properties that is essential for electrolyte secretion in human epithelial 
tissues. However, the functional consequences of CFTR-expression are multifaceted, 
encompassing much more than simply supplying a cellular cAMP-regulated Cl- conductance. 
When we expressed CFTR in Xenopus oocytes, we found that extracellular acidic pH activates a 
Cl- conductance that is, however, not due to CFTR Cl- currents. The proton activated Cl- 
conductance showed biophysical and pharmacological features of a Ca2+ dependent Cl- 
conductance (CaCC) and was clearly Ca2+ dependent. In contrast to extracellular acidification, 
intracellular acid pH did not activate CaCC. Surprisingly, apart from fully functional wtCFTR, also 
the trafficking mutant F508del-CFTR was able to confer proton sensitivity, while the gating 
mutant G551D-CFTR did not generate a proton activated Ca2+ dependent Cl- conductance. 
CFTR may induce or augment extracellular proton sensing by translocating proton receptors to 
the plasma membrane and by facilitating Ca2+ release from the endoplasmic reticulum. The data 
suggest the role of CFTR for pH sensing in bone cells and may provide a link to abnormal bone 
formation in cystic fibrosis. 
 
Key words: Cystic fibrosis transmembrane conductance regulator, CFTR, acid, protons, 
F508del-CFTR, Ca2+ activated chloride secretion, CaCC, TMEM16A 
 
Own experimental contribution: All of the experiments. 
Own writing contribution: Methods, Results, Introduction and part of Discussion. 
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INTRODUCTION 
The cystic fibrosis transmembrane conductance regulator (CFTR) is a cAMP-and protein kinase 
A (PKA)-regulated Cl- channel and a regulator of other ion channels58,59. In normal, non-cystic 
fibrosis (CF) epithelial cells and in recombinant cells overexpressing CFTR, Cl- currents with a 
linear current/voltage relationship are activated by an increase in intracellular cAMP that are not 
detected in epithelial cells derived from CF patients. CFTR is expressed in luminal membranes 
of both secretory and absorptive epithelia, where it not only generates a Cl- conductance but 
also controls a number of other ion channels and membrane conductances154. Among the many 
membrane conductances and transport processes that are controlled by CFTR, there is the well 
described relationship between the cystic fibrosis transmembrane conductance regulator (CFTR) 
and Ca2+-activated Cl- channels (CaCCs). Enhanced Ca2+ activated Cl- conductance has been 
detected in the airways of cystic fibrosis (CF) patients155,156 as well as mouse airways and 
cultured airway epithelial cells84,157. Other studies have demonstrated that CFTR has an 
inhibitory effect on CaCCs73,158.  
The question how both Cl- conductances are related has been reinforced by molecular 
identification of the novel Ca2+ dependent Cl- channel TMEM16A (anoctamin 1, ANO1)77,79,159. 
TMEM16A is a member of a family of 10 homologous proteins that exist as various splice 
variants. In mouse, it is expressed particularly in epithelial cells and smooth muscle tissues160,161. 
By analyzing Cl- transport in TMEM16A null mice, TMEM16A was identified as an essential 
component for Ca2+-dependent Cl- secretion in several epithelial tissues and mucociliary 
clearance of mouse airways81,162. 
These recent findings reinforce the concept that cAMP- and Ca2+ dependent Cl- conductances 
are due to two different molecular entities and asks for the relationship of both proteins163. In the 
present study we report a novel finding that, once again, indicates a functional relationship 
between both currents. We found that endogenous Ca2+ dependent Cl- currents present in 
Xenopus oocytes are activated by extracellular protons, however, only when CFTR is 
expressed. This is a novel finding that supports the role of CFTR as a conductance regulator, 
particularly of other Cl- channels. 
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MATERIALS AND METHODS 
cRNAs and double electrode voltage clamp: Oocytes obtained from female Xenopus laevis were 
defolliculated for 1 hr at 18°C with 1.5 mg/ml collanease type V (Sigma) in OR2 solution (in 
mmol/l): 82.5 NaCl, 2 KCl, 1 MgCl2, and 5 HEPES pH 7.55.  Oocytes were injected with 10 ng 
(47 nl double-distilled water) of cRNA encoding wt, ΔF508, or G551D CFTR. All mutants were 
constructed by PCR based site-direct mutagenesis techniques. Correct sequences were 
confirmed by restricted enzyme digestion and sequencing. Oocytes were maintained in ND97 
solution (in mmol/l): 96 NaCl, 2 KCl, 1.8 CaCl2, 1 MgCl2, 5 HEPES, 2.5 Na-pyruvate, 0.5 
Theopyllin, and 0.01 mg/ml Gentamycin, pH 7.55 at 18°C. 2-4 days after injection, membrane 
currents were measured by impaling an oocyte with two electrodes (Clark Instruments Ltd, 
Salisbury, UK) that filled with 2.7 mol/l KCI and a resistance of less than 1 MΩ.  The bath was 
continuously perfused at a rate of 5 ml/min with ND96 solution (in mmol/l): 96 NaCl, 2 KCl, 1.8 
CaCl2, 1 MgCl2, 5 HEPES, and 2.5 Na-pyruvate, pH 7.55.  The voltage drop across the serial 
resistance was optimized to zero using two bath electrodes and a virtual-ground head stage.  
Oocytes were voltage clamping (Oocyte clamp amplifier, Warner Instruments LLC, Hamden CT) 
from -60 to +40 mV interval, in steps of 10 mV, each 1 s.  All experiments were conducted at 
room temperature (22 °C). Incase of drug preincubation before two electrode voltage clamp 
experiments, compounds were dissolved in ND96. 
Materials: Reagents were purchased from the following sources; CFTRinh172, 4,4′-
diisothiocyanostilbene-2,2′-disulfonic acid, 2Na (DIDS), 1,2-bis(o-aminophenoxy)ethane-
N,N,N′,N′-tetraacetic acid tetra(acetoxymethyl) ester (BAPTA/AM)  and forsklolin (#344270) from 
Calbiochem; niflumic acid (NFA) carbonyl cyanide 3-chlorophenylhydrazone (CCCP), and 3-
Isobutyl-1-methylxanthine (IBMX) from Sigma. Other chemicals used were with highly analytical 
graded.  
Statistical analysis. Values were presented as mean ± SEM. Student t-test was used for 
statistical analysis. Significant difference was considered at p ≤ 0.05.   
 
RESULTS 
Extracellular acidic pH activates Cl- currents in CFTR expressing oocytes. In two electrode 
voltage clamp experiments we exposed Xenopus oocytes to extracellular acid pH of 5.5, which 
had no effects on the membrane conductance (Figure 1). In contrast when oocytes expressed 
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Figure 1. Extracellular acidosis induces currents in CFTR expressing oocytes. A) Original 
recordings from oocytes injected with water (control) or expressing wtCFTR, ΔF508-CFTR, or G551D-
CFTR before and after exposure to acidic extracellular bath solution (pH 5.5). B) Summary of whole cell 
conductances obtained from oocytes expressing wtCFTR or different CFTR mutants in the presence of 
normal (pH 7.5) and acidic (pH 5.5), and effects of inhibition of CFTR by 10 μM CFTRinh172 for 15-30 min 
before applying pH 5.5. C) Summary of whole cell conductances activated by 1 mM IBMX and 2 μM 
forskolin. Data represent mean ± SEM, (n) = number of experiments. * indicates significant difference 
when compared to control (paired t-test, p ≤ 0.05). 
wtCFTR, acidic pH activated a whole cell conductance that showed a pronounced outward 
rectification and that was not inhibited by 10 µM of the CFTRinh172. Expression of functional 
CFTR was demonstrated by activation of a CFTR-typical, linear Cl- conductance by IBMX and 
Forskolin (1 mM/2 µM). Thus expression of wtCFTR suggests activation of a conductance by 
extracellular acidosis, which shows features of the endogenous Ca2+ activated Cl- conductance 
in Xenopus oocytes. Interestingly extracellular acidic pH also activated a whole cell conductance 
in oocytes expressing the most common CFTR-mutant ΔF508-CFTR. In fact the H+ activated 
conductance was even larger in ΔF508-CFTR expressing cells, although I/F activated CFTR 
conductance was low as expected. In contrast, expression of the non-functional mutant G551D-
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CFTR did not produce any H+ activated conductance (Figure 1). Taken together expression of 
wtCFTR and ΔF508-CFTR supply a H+ sensitive whole cell conductance in Xenopus oocytes.  
It has been previously reported that in pre-activated CFTR, cytosolic acidosis enhances CFTR 
activity145. We therefore examined whether extracellular acidification possible lowers intracellular 
pH and affects CFTR activity, which could be related to our findings. In order to induce 
intracellular acidification, the protonophore carbonyl cyanide m-chloro phenylhydrazone (CCCP), 
was applied in the presence of variable extracellular pH (Figure 2). Interestingly, intracellular 
acidification did neither activate a whole cell current in water injected control oocytes nor in 
wtCFTR expressing oocytes. This result suggests that activation of whole cell currents is due to 
extracellular but not intracellular acidification and that a H+ gradient is required to activate the 
endogenous current. 
 
Extracellular H+ activate Ca2+ dependent Cl- currents: We analyzed the whole cell current that 
was activated by extracellular H+ in CFTR-expressing oocytes. Strong outward rectification of 
the current suggested activation of endogenous Ca2+ dependent Cl- currents (Figure 3A,C). We 
therefore replaced extracellular Cl- by NO3- or I- and found that acid induced currents were 
augmented, by NO3- and I- (I->NO3->Cl-) indicating a halide permeability sequence typical for 
Ca2+ dependent Cl- currents (CaCC) (Figure 3). We also applied the typical inhibitors of CaCC, 
di-isothiocyano-stilbene-2',2'-sulfonic acid (DIDS) and niflumic acid (NFA; both 100 µM) to the 
Figure 2. Intracellular acidification 
does not activate CaCC. A) 
Original recordings from a water 
injected control oocyte and a 
wtCFTR expressing oocyte, 
incubated with the protonophore 
CCCP (10 µM), and effects of 
acidification of the extracellular bath 
solution.  B) Summary of whole cell 
conductances obtained from control 
oocytes and wtCFTR expressing 
oocytes when treated with CCCP 
and exposed to solutions of different 
extracellular pH. Data represent 
mean ± SEM, (n) = number of 
experiments. * indicates significant 
difference when compared to control 
(paired t-test, p ≤ 0.05). # indicates 
significant difference when 
compared to pH 7.5 (unpaired t-test, 
p ≤ 0.05). 
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extracellular bath solution. We found that both inhibitors completely blocked H+ activated whole 
cell conductances (Figure 4). Finally, we acidified the extracellular compartment in the absence 
of extracellular Ca2+ which, however, did not affect activation of CaCC (Figure 5). In contrast, 
when oocytes were preincubated with the Ca2+ chelator 1,2-Bis(2-Aminophenoxy)ethane-
N,N,N′,N′-tetraacetic acid (BAPTA; 50 µM), activation of CacC by extracellular H+ was 
completely abolished. Similar was observed in the presence of BAPTA/extracellular Ca2+ free 
solution (Figure 5). These results indicate that extracellular acidification increases the 
intracellular Ca2+ concentration, which in turn activates CaCC, a process that is strictly 
dependent on the presence of CFTR. 
CFTR may establish or translocate an unknown H+ receptor to the plasma membrane: The 
results suggests that CFTR establishes a H+ sensitive mechanism at the plasma membrane, that 
is coupled to an intracellular phoshoplipase C/IP3/Ca2+ - dependent signalling pathway. CFTR 
itself may also form a proton sensor. However, it has previously reported that CFTR is able to 
translocate functional receptor complexes to the plasma membrane, such as the 
Figure 3. Ion selectivity of the H+ activated currents indicates activation of CaCC. A) Original 
recordings from a CFTR-expressing oocyte exposed to extracellular pH 5.5 in the presence of different 
extracellular anions. B) Summary of whole cell conductances obtained from CFTR-expressing oocytes 
in the presence of different extracellular anions, before and after treatment with extracellular acidic pH 
5.5. C) Current-voltage (IV) relationships of currents activated by extracellular acidic pH in wtCFTR 
expressing oocytes exposed to different extracellular anions. Data represent mean ± SEM, (n) = number 
of experiments. * indicates significant difference when compared to control (paired t-test, p ≤ 0.05). # 
indicates significant difference in the presence of different extracellular halides (unpaired t-test, p ≤ 
0.05). 
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lysophosphatidic acid (LPA) receptor that inhibits cholera toxin-induced secretory diarrhea 
through CFTR-dependent protein interactions131. We found that oocytes also activate a Ca2+ 
dependent Cl- current when exposed to 50 µM LPA (Figure 6). Thus oocytes express LPA-
receptors that are coupled to intracellular Ca2+ signalling and activation of CaCC164. Notably, the 
LPA induced CaCC was augmented in CFTR expressing oocytes, suggesting that the presence 
of CFTR establishes a membrane localized signalling complex that augments Ca2+ signalling 
and activation of CaCC. When LPA was applied in the presence of extracellular acidic pH, the 
total current that was activated by LPA was larger, suggesting additive effects of CFTR on LPA 
and H+ induced signal transduction and activation of CaCC. We therefore postulate that CFTR 
installs a H+ sensitive mechanism at the plasma membrane by translocating a H+ receptor to the 
membrane or by being itself H+ sensitive. Exposure to H+ increases intracellular Ca2+ and 
activates CaCC. 
 
DISCUSSION 
Extracellular acidic pH activates CaCC in CFTR expressing oocytes: We reported in the present 
study that expression of CFTR confers proton sensitivity to Xenopus oocytes. The data indicate 
that extracellular H+/acidification activates the Ca2+ activated Cl- conductance that is expressed 
Figure 4. The H+ activated 
current is blocked by 
inhibitors of CaCC. A) 
Original recording obtained 
from an oocyte expressing 
wtCFTR and exposed to 
extracellular pH 5.5 in the 
absence or presence of DIDS 
(100 μM) or NFA (100 µM). B) 
Summary of whole cell 
conductances obtained from 
wtCFTR expressing oocytes 
exposed to extracellular pH 
5.5 in the absence or 
presence of DIDS (100 μM) or 
NFA (100 µM). Data represent 
mean ± SEM, (n) = number of 
experiments. * indicates 
significant difference when 
compared to control (paired t-
test, p ≤ 0.05). 
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endogenously in Xenopus oocytes, but only when functional CFTR is present. Activation of 
CaCC is independent of stimulation of CFTR but is affected by CFTR-mutations. Notably, the 
most common CFTR mutation ΔF508-CFTR, which poorly traffics to the cell membrane in 
mammalian cells, but which is well expressed in Xenopus oocytes, confers an even enhanced 
H+ sensitivity when compared to wtCFTR4,165. Once ΔF508-CFTR escapes from degradation and 
continues its way from the endoplasmic reticulum to the plasma membrane, the protein is 
actually able to form functional Cl- channels with reduced open probability166. Due to the low 
temperature at which oocytes exist, maturation of ΔF508-CFTR is improved and ΔF508-CFTR-
induced Cl- currents are generally much higher than in mammalian cells167,168.  
However, the surprising finding was that ΔF508-CFTR produced an even larger Ca2+ activated 
Cl- current than wtCFTR, although expression of wtCFTR is expected to be more efficient than 
for ΔF508-CFTR. A possible answer to this question may give our recent study showing that ER-
trapped ΔF508-CFTR can operate as a counter ion channel for Cl- that facilitates release of Ca2+ 
from the endoplasmic reticulum similar to Bestrophin 1169. The present results from G551D-
CFTR expressing oocytes indicate suggest that the ability of CFTR to conduct Cl- is important to 
allow activation of CaCC by extracellular protons, although CFTR currents do not need to be 
activated to allow activation of CaCC. G551D-CFTR is a CFTR mutant which is properly 
expressed in cell membranes but which does not open upon stimulation with cAMP/PKA170. 
Figure 5. H+ activation of CaCC 
requires intracellular Ca2+. A) 
Original recording of a wtCFTR 
expressing oocyte exposed to 
extracellular pH 5.5 in the presence 
of a Ca2+ free bath solution, after 
incubation with BAPTA (50 µM) or 
both. B) Summary of whole cell 
conductances obtained from CFTR-
expressing oocytes exposed to 
extracellular pH 5.5 in the presence 
of a Ca2+ free bath solution, after 
incubation with BAPTA (50 µM) or 
both. Data represent mean ± SEM, 
(n) = number of experiments. * 
indicates significant difference 
when compared to control (paired t-
test, p ≤ 0.05).  
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Membrane-translocation of a H+ receptor, facilitating H+ induced signalling, or CFTR as a H+ 
receptor? The current data do not provide a definite answer as to how H+ sensing is induced by 
CFTR. However, it is well known that CFTR translocates protein complexes to the apical 
membrane of epithelial cells by forming functional microdomains154,171. A spatiotemporal 
coupling of cAMP transporter to CFTR chloride channel function in gut epithelia has been 
demonstrated earlier132. Thus macromsolecular complexes consisting of receptors, CFTR and 
scaffolding proteins form functional units, coupling ß2-adrenergic and LPA receptors to 
CFTR129,131. It is also well esthablished that signaling pathways exist in Xenopus oocytes 
between LPA receptors, sphingosine-1-phosphate and phospholipase164. As suggested from the 
present experiments, CFTR may translocate LPA receptors to the cell membrane thus 
enhancing LPA-induced Cl- currents (Figure 6). CFTR may also simply enhance coupling 
between LPA- and putative H+-receptors and intracellular signalling molecules. However, since 
the ability of CFTR to produce H+ sensitivity was depending on its ability to generate a Cl- 
current, CFTR itself could also serve as H+ receptor. 
Figure 6. CFTR augments 
LPA-activation of CaCC. A) 
Original recordings of a control 
oocyte and a wtCFTR 
expressing oocyte exposed to 
lysophosphatidic acid (LPA, 50 
µM). B) Summary of whole cell 
conductances obtained from 
control oocytes and from CFTR-
expressing oocytes exposed to 
LPA in the presence of 
extracellular pH 7.5 or pH 5.5 
Data represent mean ± SEM, 
(n) = number of experiments. * 
indicates significant difference 
when compared to control 
(paired t-test, p ≤ 0.05). # 
indicates significant difference 
between the different groups 
(unpaired t-test, p ≤ 0.05). 
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Possible physiological and clinical role of CFTR-dependent proton sensitivity: The results 
described in the present study would provide a mechanism how Cl- secretion by Ca2+ activated 
Cl- currents is coupled to extracellular pH, a process that may be of significant relevance in 
tissues such as airways, pancreas or duodenum. We may speculate that the ability of CFTR to 
confer proton sensitivity may be important for proper function of ameloblasts, odontoblasts and 
bone cells172. Abnormal bone formation, osteopenia and osteoporosis are well known problems 
in cystic fibrosis173-176. It is also known for long that both the functions of osteoblasts and 
osteoclasts is regulated by extracellular pH177,178. Subsequent studies should therefore elaborate 
the role of CFTR for pH sensing in bone cells and its possible role for abnormal bone formation 
in cystic fibrosis. 
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CHAPTER 6.  
 
Summary 
Cystic Fibrosis Transmembrane conductance Regulator (CFTR) is a cAMP dependent Cl- 
channel that is expressed mainly on the apical membrane of epithelial cells. CFTR plays an 
essential role in electrolyte and water homeostasis. Defects in CFTR cause CF disease, which is 
the most common lethal genetic disorder among Caucasians. Besides functioning as a Cl- 
channel, CFTR also acts as a regulator of other channels and transporters. Although CFTR has 
been known for more than 20 years, many questions regarding CFTR regulations and functions 
remain to be answered. In the present thesis, we performed various experiments in an attempt 
to understand CFTR in several aspects, including CFTR-regulation by AMPK in vitro and in vivo, 
the role of the S573C CFTR mutation for the risk to develop pancreatitis, and a novel role of 
CFTR in proton sensing and regulating CaCC.  
 
Regulation of CFTR by AMPK in vivo 
The present study has clarified the role of AMPK for epithelial Cl- transport in vivo using 
AMPKα1-/- mice. The data demonstrate a significant role of AMPK in regulating CFTR. In real 
short circuit Ussing chamber experiment, an increase in CFTR Cl- current is observed in the 
colon of AMPKα1-/- mice when exposed to cAMP. Unlike wild type littermates, the elevated 
cAMP-dependent Cl- current in the AMPKα1-/- colon is insensitive to the AMPK activator 
phenformin. Furthermore, rectal potential difference (RPD) measurements indicate that 
AMPKα1-/- mice have an increased RPD both non-stimulated and after exposure to cAMP. 
These data suggested enhanced activity of CFTR in the large intestine of AMPKα1-/- mice. In 
correlation to previous in vitro observations, data from the present study demonstrate that AMPK 
inhibits CFTR in vivo. 
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Mechanistic insight into control of CFTR by AMPK 
To identify the AMPK phosphorylation sites in CFTR and to find the mechanisms underlying 
AMPK regulation of CFTR, Xenopus oocytes were used to overexpress different CFTR 
mutations, and the whole cell currents of the overexpressed oocytes were measured using the 
double electrode voltage clamp (DEVC) technique. In contrast to previous observations, this 
study demonstrates that S737 and S768 are phosphorylated by AMPK rather than PKA. In 
Xenopus oocytes, single or multiple mutations of S737 and S768 to alanine increase CFTR 
whole cell currents around 4-fold. Moreover, in non-activated cells, S737A and S768A increase 
the basal CFTR Cl- conductance around 5-fold. The elevated conductance is insensitive to the 
AMPK inhibitor phenformin and the AMPK activator compound C. Taken together, we 
demonstrate that AMPK inhibits PKA activation of CFTR. Moreover, AMPK indeed constitutively 
phosphorylates CFTR and keeps the channel shut at basal levels. We associated this finding to 
a spatiotemporal regulation of CFTR by cAMP. Data from the present study suggest a 
constitutive inhibition of CFTR by a tonic baseline AMPK activity. Because AMPK can also be 
activated without any detectable changes in the global AMP/ATP ratio, it is likely that AMPK 
regulation of CFTR is also controlled locally. The scenario can perhaps be described as AMP 
being generated by a Shank2/PDE complex bound to CFTR’s PDZ domain. PDE degrades 
cAMP to AMP, increasing the AMP/ATP ratio close to CFTR, and thus activating AMPK. The 
activated AMPK therefore inhibits CFTR and keeps the channel close under non-stimulated 
conditions. 
 
Metformin treatment of diabetes mellitus increases the risk of pancreatitis in 
patients bearing the CFTR-mutation S573C 
Metformin is an AMPK activator and is a drug used for the treatment of diabetes type II. Lactic 
acidosis is a common secondary complication of metformin therapy, especially in patients with 
renal dysfunction, alcohol abuse, or liver disease. Patients with renal failure have been reported 
to develop the pancreatitis after metformin therapy. We examined the effects of metformin 
treatment on a pancreatitis-related S573C-CFTR mutation. The results demonstrate a slight but 
significant reduction of S573C-CFTR whole cell currents that are further inhibited by metformin. 
On the other hand, metformin treatment of wtCFTR does not affect whole cell current induced by 
cAMP. These data suggest that the S573C mutation increases the sensitivity towards AMPK, 
However in vitro phosphorylation experiments reveal the same pattern of AMPK phosphorylation 
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in wt and S573A-CFTR. Because lactic acidosis has been found during metformin therapy, and 
because CFTR is essential to control the pH balance in the pancreas, we challenged wt and 
S573C CFTR expressing oocytes by exposing them to acidic pH. The results demonstrate that 
intracellular acidificaiton reduces activation of wtCFTR, but almost completely abolishes Cl- 
currents produced by S573C-CFTR.  
Taken together these data imply that patients carrying the S573C mutation have only a slight 
defect in CFTR Cl- currents. However, under metformin treatment, the Cl- transport in patients 
carrying the S573C mutation is largely reduced. Thus S573C-carrier have a higher risk in 
developing a pancreatitis after metformin therapy. 
 
CFTR induces acid sensing and H+ activated Cl- transport 
In the last section of the present thesis we identified a novel role of CFTR for detection of the 
extracellular proton concentration and regulation of the Ca2+ activated Cl- current. In wtCFTR 
expressing Xenopus oocytes, we observed a Ca2+ activated Cl- current after exposure of the 
oocytes to extracellular acidic pH. This current was strongly outwardly rectifying, sensitive to 
DIDS and NPPB, and required intracellular Ca2+ for the activation. We hypothesize that CFTR 
translocate H+-receptors to the plasma membrane and extracellular protons binding to these 
receptors induces an increase in intracellular [Ca2+]. We speculate that CFTR-dependent H+-
sensing may be essential for bone metabolism, since CFTR is expressed in bone cells and 
because CF-patients suffer from osteoporosis. 
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